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ABSTRACT 
Adhesion proteins maintain cell-cell interactions, which are critical for tissue formation and the 
hierarchical organization of all multicellular organisms, and among them, cadherins are the major 
transmembrane cell-cell adhesion proteins in all vertebrate tissues. Regulation of cadherin 
mediated adhesion at cell-cell junctions is crucial to our understanding of development and 
disease. This thesis focuses on the regulation of cadherin adhesion, which can be influenced by its 
extracellular domain interactions, ligand or antibody binding, post translational modifications, or 
inside out signaling from cytoplasmic binding proteins.  
In this thesis, micropipette-based adhesion frequency measurements of cadherin-mediated, 
cell-cell binding kinetics identified a unique kinetic signature that appears to reflect both adhesive 
(trans) bonds between cadherins on opposing cells and lateral (cis) interactions between cadherins 
on the same cell. These kinetic measurements were used to assess the impact of confinement within 
narrow adhesion zones on the assembly of intercellular adhesions. Specifically, a unique kinetic 
signature suggested the formation of lateral interactions that were not detected in solution binding 
assays. Mutations postulated to disrupt lateral cadherin association altered the kinetic signature, 
but did not affect cadherin binding affinity. Perturbed kinetics further correlated with altered 
cadherin clustering at cell-cell junctions, wound healing dynamics, and paracellular permeability.  
Adhesion frequency measurements were used to demonstrate the allosteric regulation of 
cadherin adhesive function. In this thesis, measured kinetics of cadherin-mediated intercellular 
adhesion demonstrated quantitatively that activating anti-E-cadherin monoclonal antibodies or the 
dephosphorylation of a cytoplasmic binding partner, p120 catenin, increased the homophilic 
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binding affinity of E-cadherin on Colo 205 cells. Further studies of Colo 205 cells demonstrated 
that four treatments, which similarly altered p120 catenin phosphorylation resulted in 
quantitatively similar enhancement in E-cadherin affinity.  
Using this approach, I further investigated the effect of N-linked and O-linked 
glycosylation on E-cadherin activity and function. Results revealed that, contrary to the influence 
of glycosylation on N-cadherin function, N-glycosylation of E-cadherin in the EC4 and EC5 
domains negatively regulated cadherin adhesion, by altering binding kinetics and clustering at cell-
cell junctions. This suggests the influence of N-glycosylation depends on its position in the 
cadherin ectodomain. 
In conclusion, this dissertation describes studies, which elucidated different mechanisms 
regulating cadherin adhesive function. Results showed that cadherin binding is regulated by its 
ectodomain interactions at cell-cell junctions, by glycosylation, and by allosteric inside-out 
signaling. These findings were enabled by the adhesion frequency measurements, which enabled 
quantitative assessment of cadherin binding function, in the native context of the cell membrane 
and cytosolic binding partners.  
 iv 
 
ACKNOWLEDGEMENTS 
Being a ritualistic theist practicing science, my religion can be determined by the following 
Sanskrit verse: “Matru devo bhava, Pitru devo bhava, Acharya devo bhava”. It means a person 
for whom the mother is god, the father is god, and the teacher is god. They are the first three 
persons I would like to acknowledge. My mother and father, both have been great teachers to me 
in life and towards shaping my career.  I would literally not have been anything without them.  
Now comes the time to acknowledge my PI, my Acharya, my guru, Prof. Deborah 
Leckband. Her unfathomable faith in me has been the foremost driving force to complete my PhD 
under her guidance. She has stood for me not only in all my good times, but very crucially during 
the worst periods of my life. Her mentorship has been nothing short of a blessing, both 
professionally, and in shaping my life itself. I thank her for the innumerable interactions which 
have had a profound impact on my career. I move forward only with her blessings and hope that I 
stay true to her faith in me.  
During the course of my graduate studies, there were many people who contributed to my 
success and completion of my Ph.D, and still continue to be an inspiration. I would definitely like 
to thank my dissertation committee for their valuable feedback on my seminars and their support: 
Prof. William Brieher has been an advisor and a friend alike. Prof. Susan Martinis has been truly 
supportive and taught me how to advance my presentation skills. Prof. Emad Tajkhorshid has been 
a very receptive and thought provoking member of my committee. I would also thank Prof John 
Gerlt who was my qualifying exam committee member. I thank Prof. Maria Spies and Prof. 
Supriya Prasanth for their advisory role and mentorship. 
 v 
 
The Department of Biochemistry staff: Jeffrey Goldberg and Cara Day have been 
especially helpful throughout, and have always been warm and welcoming. I’d also like to thank 
the Inorganic and Materials office staff, Chemical Engineering office staff and the SCS mail room 
staff for all their dedication in making day to day work a smoother task. I thank Sandy McMasters 
for her assistance with media preparations and friendly gossip. I thank Dr. Barbara Pilas and Dr. 
Angela Kouris at the flow cytometry facility for their assistance. 
I would like to immensely thank all of my co-workers during my graduate studies, for their 
assistance, and for their camaraderie as we all tackled scientific and personal challenges. 
Especially I thank all of them for putting up with my jokes. My special thanks to Dr. Matt Langer 
who has been my graduate student mentor in my initial years in the lab, and taught me the skills 
required for my project. I especially acknowledge Saiko Rosenberger, not only for her technical 
assistance, but being there for me like a second mother, second to none.  
My undergraduate trainees have played a special role not only in assisting me with my 
projects, but also being there as great friends. I would especially mention Meridith Kisting, for her 
brilliant work and also being a source of inspiration for me. I would like to thank Rahul Koshy, Ji-
Hoon Shin and Shyam Saladi who directly worked with me speeding up my projects. Among my 
friendliest undergrads whom I would acknowledge are Daniel Yoakum, Dominic Lullo, Neha 
Shiroor and Muhammed Munim.  
I thank Dr. Changying Xue, Dr. Jun Wu, Dr. Roberto Andersen, Dr. Poonam Sehgal, Dr. 
Ryan Huang and Dr. Lydia Kisley for being great postdoc mentors, I really have learned a lot from 
them. My graduate student colleagues have been the spine of my support in the lab – Jillian, 
Samantha, Ismaeel, Johana, Sangwook, Byung-chan, Hamid, Arka, Zainab, Xinyu, Tajin, Vinh 
 vi 
 
and Ellen. The lab has truly been a congenial atmosphere to work and an honor to be there with 
such fantastic colleagues. Jillian and Sam, I can’t thank you enough for teaching me to be an 
American in America and giving me latitude! 
I would also like to thank the collaborators from other institutions who contributed to this 
work. I especially thank Prof. Barry Gumbiner at the University of Virginia and his postdocs Dr. 
Yuliya Petrova, Dr. Stephanie Maiden and Martha Spano, for providing me the seed for my 
activating antibody project. I would like to thank Prof. Taekjip Ha and his graduate student 
Seongjin Park for their collaboration on microscopy studies. Finally, I’d like to thank Dr. Cheng 
Zhu at Georgia Tech for developing the micropipette technique which was used in these studies. 
I would like to once again thank my family, including my dear sister Nikhila. I would like 
to thank my dearest of friends at Urbana-Champaign, who have held my hand during the course 
of this PhD: Atul, Kapil, Subha, Sarthak, Sourabh, Soham, Punit and Veena. I gratefully 
acknowledge the support system I received from the organizations I was involved with: the Indian 
Graduate Students Association (IGSA) and ASHA for Education.  It helped hone my 
organizational skills as well as make great friends on this journey. 
 
  
 vii 
 
Table of Contents 
Chapter 1: Introduction.........................................................................................................1 
1.1.Overview of Intercellular Adhesion...................................................................................1 
1.2.Cadherins............................................................................................................................2 
1.3.Regulation of Ectodomain-Mediated Cadherin Adhesion.......................... ......................4 
1.4.Inside Out Regulation Of Cadherin Adhesion...................................................................11 
1.5.The Disconnect: How do Cadherin Extracellular Interactions and Intracellular Response 
Via Cytoplasmic Domain Correlate? ................................................................................14 
1.6.Questions Addressed In This Thesis.................................................................................15 
1.7.Figures...............................................................................................................................17  
Chapter 2: Adhesion Frequency Measurements of Cadherin Kinetics...........................21 
2.1 Introduction.......................................................................................................................21 
2.2 Materials and Methods......................................................................................................22 
2.3 Results-Example Of Classical Cadherins...... ...................................................................29 
2.4 Figures...............................................................................................................................32 
Chapter 3: Allosteric Regulation of Cadherin Adhesion..................................................39 
3.1 Introduction......................................................................................................................39 
3.2 Materials and Methods.....................................................................................................41 
3.3 Results..............................................................................................................................47 
3.4 Discussion........................................................................................................................55 
3.5 Figures and Tables...........................................................................................................61 
Chapter 4: Kinetic Measurements Reveal Complex Cadherin Interactions at Confined 
Cell-Cell Junctions...............................................................................................................75 
4.1 Introduction......................................................................................................................75 
4.2 Materials and Methods.....................................................................................................78 
4.3 Results..............................................................................................................................83 
4.4 Discussion........................................................................................................................87 
4.5 Figures and Tables...........................................................................................................92 
Chapter 5: Role of Glycosylation in E-cadherin Adhesion..............................................99 
5.1 Introduction......................................................................................................................99 
5.2 Materials and Methods....................................................................................................101 
5.3 Results.............................................................................................................................103 
5.4 Discussion.......................................................................................................................105 
5.5 Figures and Tables......................................................................................................... 109 
Chapter 6: Conclusions and Future Work.......................................................................116 
6.1 Conclusions.....................................................................................................................116 
6.2 Future Work....................................................................................................................118 
      References............................................................................................................................119 
 
 1 
 
CHAPTER 1  
Introduction 
 
1.1 Overview Of Intercellular Cell Adhesion 
Multicellular organisms which are capable of functioning as a unit have a complex organization 
of cells that must adhere to form tissues, and continually rearrange to assemble biological barriers 
to form distinct tissue compartments (Takeichi et al. 1994; Gumbiner 2005; Niessen et al. 2011). 
Cell adhesion molecules are critical to the formation of intercellular contacts between the billions 
of cells in multicellular organisms. Hence, understanding mechanisms of cell-cell adhesion and its 
regulation are key to understanding fundamental mechanisms in development and disease. 
Cell adhesion proteins are critical to the formation of robust adhesion between adjacent 
cells and the cell and its extracellular matrix (ECM). Adhesive interactions between the cell and 
its surrounding extracellular matrix are mediated mainly through integrins (Gumbiner 1996). 
Intercellular adhesion is mediated by various immunoglobulin-type cell adhesion molecules 
(CAMs), and junction proteins like cadherins (calcium dependent adhesion proteins), desmosomal 
cadherins and nectins, as well as tight junction proteins such as claudins and occludins (Hartsock 
and Nelson 2008; Chen et al. 2009).  Of these, the cadherin superfamily is essential for the dynamic 
regulation of cell-cell contacts and the maintenance of tissue barrier integrity (Nagafuchi et al. 
1987; Takeichi 1991). In embryonic development, cadherins control both the separation of cells 
into distinct tissue layers and their fusion. Additionally, the shapes of tissues due to cell 
rearrangements, transitions between cell states (epithelial vs mesenchymal), long-range migration 
of cells, extension of neuronal processes, and the formation of synapses between neurons are 
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regulated by cadherins (Gumbiner 2005; Ratheesh and Yap 2010; Niessen et al. 2011; Brieher and 
Yap 2013; Leckband 2013; Leckband and de Rooij 2014; Lecuit and Yap 2015).  
The regulation of cell-cell adhesion by cadherins and cadherin-associated proteins, catenins 
is the focus of this thesis. This introductory chapter discusses the current state of knowledge 
regarding the molecular basis of cadherin adhesion, and its regulation by cadherin signaling, by 
cytosolic binding proteins, and by the underlying biochemical/biophysical mechanisms involved.  
1.2 Cadherins 
1.2.1 Cadherin Structure 
Cadherins are calcium dependent transmembrane adhesion glycoproteins that are the main 
components of cell-cell junctions (Shimoyama et al. 1989). Cadherins can be divided into six 
major subdivisions: classical (or type I) cadherins, atypical (type II) cadherins, desmosomal 
cadherins, flamingo cadherins, and protocadherins, as well as a number of solitary members 
(Niessen et al. 2011). The most extensively studied cadherin structures are of the type I cadherins 
Epithelial (E) - cadherin and Neuronal (N) - cadherin. Similarly, the structures of type II cadherins, 
Vascular Endothelial (VE) - cadherin (Brasch et al. 2011) and T/H (Heart) - cadherin (Ciatto et al. 
2010) have also been studied extensively.  
The overall structure of classical cadherins protein consists of a single transmembrane 
polypeptide comprising the extracellular domain, a transmembrane domain, and a cytoplasmic 
domain (Leckband and Prakasam 2006). The extracellular segment folds into 5 extracellular EC 
domains, named EC1-EC5 from the N-terminal (Boggon et al. 2002) (Fig 1.1). Each individual 
EC domain consists of ~110 residues that form seven anti-parallel β-strands arranged into an 
immunoglobulin-like β-sandwich fold (Brasch et al. 2011) (Fig 1.1). The single pass 
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transmembrane segment is an alpha helical domain of 34 amino acids.  Finally, the intrinsically 
disordered cytoplasmic domain binds to cytosolic proteins, mostly catenins that are involved in 
actin coupling and the regulation of cadherin adhesion (Fig 1.2). 
Calcium ions are indispensable for cadherin activity. The junctions between contiguous 
EC domains are rigidified by the chelation of three calcium ions which bind to negatively charged 
aspartates and glutamates in DXD, DRE, or a DXNDNAPXF motifs (Ringwald et al. 1987; 
Tomschy et al. 1996). Calcium depletion disrupts the cadherin adhesive function, and the protein 
becomes more flexible and protease sensitive. The reported calcium dissociation constant is 49 
µM, and extracellular calcium is typically ~1.5mM (Prakasam et al. 2006). So it is essential to 
have calcium in experiments investigating cadherins. 
1.2.2 Cadherin Post-translational modifications 
Cadherins are also glycoproteins, with a number of N-linked and O-linked glycosylation sites 
along the extracellular domain (Zhao et al. 2008; Vester-Christensen et al. 2013; Winterhalter et 
al. 2013). Glycans comprise about 20% of the molecular weight of the mature protein (Liwosz et 
al. 2006; Winterhalter et al. 2013). The extent of glycosylation has been characterized for both 
human N-cadherin and mouse E-cadherin. However, little is known regarding the structural details 
of the carbohydrates, because crystal structures are of the non-glycosylated or deglycosylated 
proteins (Boggon et al. 2002; Patel et al. 2006; Harrison et al. 2010). 
The position and type of glycans on the cadherin structure appear to affect its function. 
Cadherins feature several N-glycosylation sites along the ectodomain backbone, and glycosylation 
is frequently involved in trafficking to the membrane (Zhao et al. 2008a; Zhao et al. 2008b; Zhou 
et al. 2008). Additionally, cadherin hyper-glycosylation is a hallmark of several types of cancer 
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(Pinho et al. 2009a; Pinho et al. 2011). Aberrant E-cadherin glycosylation has also been linked to 
morphological defects in Drosophila embryos (Zhang et al. 2014). The N-glycosylation of N-
cadherin was also shown to play a critical role regulating intercellular junctions. For example, the 
removal of all 8 N-glycosylation sites on the extracellular domain of N-cadherin appeared to 
increase the stability of intercellular junctions (Guo et al. 2009; Langer et al. 2012). Namely, cells 
exhibited reduced collective motility in a wound-healing assay. Chemical cross-linking studies 
also indicated that removing N-glycosylation sites increased the number of N-cadherin dimers on 
the cell surface (Guo et al. 2009). 
In addition, O-linked mannosylation of the E-cadherin ectodomain appears to affect its 
adhesive function (Lommel et al. 2013; Winterhalter et al. 2013). Mouse embryos deficient in O-
mannosyl transferases were incapable of progressing further than the morula stage, and 
development was arrested before blastocyst formation (Lommel et al. 2013). Results obtained with 
antibodies targeting cell surface O-mannosyl links further suggested that blocking O-
mannosylation sites disrupted cell-cell cohesion. 
1.3 Regulation of ectodomain-mediated cadherin adhesion  
1.3.1 Adhesive (trans-) dimerization of cadherin ectodomains via EC1 domain interaction 
The processed type I cadherin polypeptide begins with an unstructured 10 amino acid sequence at 
the N-terminus of EC-1. The first four amino acids, “DWVI” is conserved in all type I classical 
cadherins (Ozawa and Kemler 1990; Handschuh et al. 2001). The first structure of the entire 
ectodomain (EC 1-5) was obtained with Xenopus cleavage-stage (C-) cadherin (Boggon et al. 
2002) (Fig 1.1A). This structure, as well as prior structures of N-terminal domain fragments EC1 
or EC1-EC2 identified the “strand dimer” as a potential adhesive interface. In the strand dimer, a 
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side chain from Trp2 (W2) inserted into a complementary hydrophobic pocket on EC1 of the 
opposite protein (Fig 1.1B). This is commonly referred to as the adhesive (trans) or “strand-
swapped dimer”. Analytical ultra-centrifugation and surface plasmon resonance (SPR) quantified 
the affinity of trans dimers. Mutating the conserved Tryptophan 2 to alanine (W2A) reduced the 
apparent affinity by 10-fold, and significantly reduced cell-cell aggregation (Katsamba et al. 2009; 
Harrison et al. 2010). The other amino acids in the flexible strand also play an important role in 
the interaction between tryptophan and the hydrophobic pocket. For e.g., mutating aspartate 1 to 
alanine (D1A) increases the binding affinity by removing the negative charge associated with the 
aspartate sidechain. Also proline to alanine - P5A and P6A mutations increase the affinity, 
presumably due to increased chain flexibility (Katsamba et al. 2009; Vendome et al. 2011). 
Conversely, adding even one amino acid before the Aspartate D1 lowers the cadherin trans 
dimerization affinity (Posy et al. 2008).  
1.3.2 Homophilic cadherin interactions involving other ectodomains 
Most initial experiments concentrated on the trans dimerization mechanism mediated by the EC1 
domain, and solution binding measurements did not identify any other domain interactions. Based 
on solution binding measurements, it appeared as if only trans EC1 dimers formed between soluble 
ectodomains.  
Detection of additional interactions using biophysical approaches 
Cadherin binding interactions were experimentally evaluated using the Surface Force Apparatus 
(SFA). This approach quantifies the interaction energy between two surfaces as function of the 
separation distance. The SFA technique uses interferometry to measure the absolute distance 
between two surfaces, with ±0.1 nm resolution, and quantifies the normalized force between the 
 6 
 
two surfaces using a sensitive force-measuring spring (±1nN) (Leckband, 1995). Surface force 
measurements of adhesion between immobilized, oriented cadherin monolayers on two apposed 
surfaces identified binding at three distinct surface separations (39 nm, 32 nm, and 26 nm) 
(Sivasankar et al., 1999). When only the outer 2 extracellular domains were used, only 2 bound 
states were observed, and a domain 3 deletion mutant did not form the strongest adhesion 
corresponding to ectodomain binding at 26nm. This suggested that EC3 was critical for the 
strongest cadherin-cadherin bond detected in these measurements (Sivasankar et al., 2001). Of the 
other two cadherin-cadherin bonds, one was consistent with the strand-swap dimer (39nm) and the 
other suggested a possible weaker interaction near the EC 1-2 interface (32nm), when the adhesion 
distances were compared with crystal structures (Sivasankar et al., 2001; Harrison et al., 2010).  
Discovery of the X-dimer 
The measured affinity between W2A mutants, which do not form the strand swapped dimer, was 
10-fold lower than the wild type protein. Because this mutation abolished cell adhesion, the 
residual activity suggested the presence of an additional cadherin interaction. Single-molecule 
fluorescence resonance energy transfer measurements suggested that, before swapping N-terminal 
β-strands, E-cadherin monomers first form a non-strand-swapped, intermediate “encounter 
complex”, which is retained in the W2A mutant (Sivasankar et al. 2009; Zhang et al. 2009). 
Finally, the crystal structure the W2A mutant of E-cadherin revealed that this initial encounter 
complex, known as the ‘X-dimer’ is formed by extensive surface interactions between the base of 
the EC1 domain, EC1–2 interdomain linker region, and the apex of domain EC2 (Fig 1.3). 
Mutating lysine 14 to glutamine (K14E) in the X-dimer-binding interface did not alter the overall 
trans dimerization affinity, relative to WT cadherin, but the association rate constant was slower 
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(Harrison et al. 2010). These data suggested that the X-dimer is an initial intermediate in the 
reaction coordinate for cadherin trans dimerization (Fig 1.3).  
There were several limitations of these studies. First, solution-binding studies that 
measured force-independent properties did not consider the fact that adhesion proteins are 
influenced by their cellular environment. Secondly, these proteins cannot freely diffuse, and their 
movements are restricted to diffusion in two dimensions on membranes. Third, the fact that the 
adhesion protein interactions were affected by other segments of the protein, especially the 
potential influence of the cytoplasmic domain was not considered. Fourth, the adhesion 
measurements were made by applying force to protein bonds. Thus the binding parameters 
obtained through these measurements were dependent on the force applied during approach or 
reproach.  
Apart from possible functional perturbations stemming from the use of recombinant 
fragments, theoretical models and experimental findings indicate that affinities measured in 
solution differ quantitatively from those determined in quasi two-dimensional gaps at adhesive 
contacts. The physical and chemical constraints within adhesion zones are also predicted to alter 
the molecular mechanism(s) driving protein organization (Wu et al. 2010; Wu et al. 2011).   
Micropipette Adhesion Frequency assay: Quantitative binding measurements at cell-cell 
contact  
 In an attempt to study cell-cell adhesion in a more relevant two dimensional context involving the 
intact protein and its cellular environment, some studies used a micropipette adhesion frequency 
(MPA) assay. This technique measures the intercellular binding probability as a function of cell-
cell contact time. It has been used successfully to characterize the binding affinities and 
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dissociation rates of several membrane proteins, including selectins, T-cell receptors and other 
adhesion proteins (Chesla et al. 1998; Long et al. 2001; Zhang et al. 2005; Chien et al. 2008; Jiang 
et al. 2011; Zarnitsyna and Zhu 2011; Liu et al. 2014).  
In the adhesion frequency measurements, two cells are brought into contact repeatedly, and 
pulled away after a given contact time. As discussed in detail in Chapter 2 of this thesis, the 
measured binding probability is a function of the number of intermembrane bonds. The time 
evolution of the binding probability is a function of the binding mechanism and the 
association/dissociation rates (Chesla et al. 1998). The binding parameters can be estimated from 
fits of the binding probability to kinetic models of the proposed binding mechanism. The binding 
parameters thus measured are independent of the applied force  This approach enables 
investigations of binding mechanisms of membrane bound proteins, in the context of the 
membrane and cytosolic binding partners.  Importantly, these parameters reflect protein 
interactions within confined, pseudo two-dimensional gaps of adhesion zones between cell 
membranes (Long et al., 2001; Huang et al., 2004; Huang et al., 2007; Zarnitsyna et al., 2007; 
Chien et al., 2008; Shashikanth et al., 2016). 
Micropipette measurements of cadherin-mediated intercellular adhesion revealed a 
complex binding mechanism that was inconsistent with the simple trans-binding mechanism (see 
Fig 2.6, Chapter 2) (Chien et al. 2008). A kinetic model for the trans binding mechanism predicts 
a simple exponential rise in binding probability to a limiting, steady state plateau. However, the 
kinetic profile for cadherin adhesion occurred discontinuously in two stages. That is, there was an 
initial increase in binding probability, followed by a lag, and then a slower second increase to a 
final steady state (Chien et al. 2008; Langer et al. 2012; Shashikanth et al. 2016). This type of 
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kinetic profile was unusual, and had not been seen in micropipette measurements of other adhesion 
proteins (Chesla et al. 1998; Chesla et al. 2000).  
Adhesion frequency studies of EC domain deletion mutants of the C-cadherin extracellular 
domain showed that the first binding phase requires EC12 domains. Additionally, the EC3 domain 
was required for the lag phase and subsequent second rise to the final, higher steady-state binding 
probability. In cases where the tested cadherin lacked the EC3 domain, the kinetics exhibited a 
single exponential rise to steady state plateau, and the kinetic profile could be described by the 
equation for a simple ligand-receptor interaction (Equation 2.1, Chesla et al., 1998).  
1.3.3. Proposed lateral interactions between cadherin extracellular domains 
The broad questions raised by the different identified cadherin interactions is how they contribute 
to adhesion. While the majority of studies discussed so far showed evidence that cadherins can 
interact in trans to form adhesive interactions, there was no clear investigation as to whether 
cadherins can form higher order complexes, which could involve lateral associations between 
cadherins on the same membrane. It is known that cadherins form the basolateral and lateral 
junctions at cell-cell contacts where they organize to form punctate clusters or ‘plaques’ in 
adhesion zones (Adams et al. 1998; Adams and Nelson 1998). Super resolution imaging quantified 
the numbers and sizes of such cadherin clusters, at a spatial resolution of 20-30nm (Truong Quang 
et al. 2013; Wu et al. 2015). The latter results demonstrated that cadherins are not randomly 
distributed, but assemble into organized clusters at cell-cell junctions. Although this clustering was 
regulated by interactions with the actin cytoskeleton (Truong Quang et al. 2013) the question 
remained as to whether cadherins that assemble to form intercellular junctions, associate in the 
same way as soluble extracellular domains.   
 10 
 
The super resolution imaging, together with theoretical modeling of the cluster size 
distributions, identified some mechanisms governing the formation of large clusters of hundreds 
of cadherin proteins. However, the SR imaging alone did not establish whether lateral cadherin 
interactions also contributed to the formation of clusters at intercellular junctions. Prior biophysical 
and biochemical studies suggested that cadherins also form lateral or cis-dimers with cadherins on 
the same membrane. The first biochemical evidence for cis-dimerization was based on the 
observation that dimers of cleavage stage cadherin (C-cadherin) ectodomains immobilized on 
beads supported stronger adhesion than did immobilized C-cadherin monomers. The latter finding 
suggested that lateral dimerization was one mechanism of enhancing cadherin adhesive function 
(Brieher et al. 1996; Yap et al. 1997; Yap et al. 1998). Crystal packing contacts observed in crystals 
of cadherin EC1-5 domains identified a potential cis-binding interface (Harrison et al. 2011). In 
the crystal structures of EC1-5 domains of E-, N- and C-cadherins, an EC1 surface opposite the 
strand-swap interface interacts with the EC2 domain of an adjacent molecule, to form a putative 
cis-interaction between cadherin trans-dimers (Fig 1.4). 
 This putative cis-binding interface was not, however, observed in solution binding 
measurements, including surface plasmon resonance, nuclear magnetic resonance, or analytical 
ultracentrifugation measurements of EC1–2 or EC1-5 fragments. Nevertheless, this putative cis-
interaction does appear to contribute to the organization of cadherin extracellular domains at model 
cell-cell junctions between giant unilamellar vesicles.  Furthermore, mutations within the 
postulated cis-interface (V81D/V175D) of E-cadherin appeared to interfere with the organization 
of intercellular junctions. However, there is no biophysical evidence supporting the postulate that 
cis-interactions contribute to cadherin clustering or that interactions at cell-cell interfaces under 
confinement enhance cis-interactions. This issue is addressed in Chapter 3 of this thesis. 
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Lateral interactions affected by N-glycosylation 
Crystal structures used to identify the putative cis-binding interface were all obtained with 
hypoglycosylated proteins. Moreover, the location of an N-glycosylation site in N-cadherin 
adjacent to the putative cis-binding interface suggested that glycosylation might alter N-cadherin 
binding. Prior adhesion frequency measurements of N-cadherin and its N-glycosylation mutants 
tested whether cadherin binding kinetics could be affected.  Measurements demonstrated that N-
glycosylation does not affect the trans-binding affinity, but instead altered the adhesion frequency 
time course (Langer et al. 2012). Specifically, the kinetics measured with hypoglycosylated N-
cadherin did not exhibit the lag. Instead, the binding probability rose rapidly to the higher binding 
probability. In conjunction with prior cross-linking results, the kinetics data support a binding 
mechanism in which initial, EC1-dependent trans binding is followed by additional, lateral 
cadherin interactions that enhance binding and promote cadherin clustering. The presence of N-
glycans localized at three sites in the EC2-EC3 domains of N-cadherin slow the second step in the 
kinetic profile to modulate the junction assembly dynamics. Chapter 5 explores the hypothesis that 
N- and O-glycosylation similarly alter E-cadherin binding kinetics. 
1.4 Inside-out regulation of cadherin adhesion  
Cadherins assemble intercellular junctions by forming bonds between ectodomains, and the 
sections above concentrated on the regulation of cadherin adhesion through the ectodomain 
interactions only. However, they are also connected to the actin cytoskeleton and signaling proteins 
through interactions with cytosolic proteins. The latter interactions are essential to establishing and 
maintaining cadherin-mediated intercellular adhesions. Specifically, the highly conserved 
intracellular tail of classical cadherin associates with many different cytoplasmic proteins, which 
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are mainly composed of α-, β- and p120-catenins (Ozawa and Kemler 1992; Reynolds et al. 1992; 
Piepenhagen and Nelson 1993) (Fig 1.2). These cadherin binding partners mediate and regulate 
cadherin-dependent cell-cell adhesion, specifically by controlling cadherin association with the 
actin-myosin cytoskeleton, and by regulating its transport and recycling to the junctions. There is 
also evidence that catenins may regulate cadherin adhesive function by inside out signaling (Barry 
et al., 2014; Shashikanth et al., 2015). In addition, cadherin and the catenins are substrates for 
important kinases and phosphatases that modulate protein-protein (for example, cadherin-beta 
catenin) interactions, in ways that regulate the cadherin adhesive function (REFS). Although not 
complete, these examples illustrate a range of mechanisms that potentially regulate the adhesive 
function of cadherins. 
β - catenin 
Cadherin association with β-catenin is important for its transport to the membrane as well as 
stability (Hinck et al. 1994). β-catenin simultaneously binds to the cytoplasmic domain of cadherin 
and α-catenin, which in turn binds to F-actin (Nagafuchi and Takeichi 1989; Guger and Gumbiner 
1995).  The formation of a cadherin/β-catenin/α-catenin ternary complex is essential for linking 
cadherin-mediated cell–cell adhesion with actin dynamics (Gumbiner and McCrea 1993; 
Piepenhagen and Nelson 1993). The overall structure of β-catenin consists of an N-terminal tail 
containing the α-catenin-binding site, a central armadillo domain that binds to the cytoplasmic 
region of cadherin, and a C-terminal tail (Barth et al. 1997). Regulatory phosphorylation and 
dephosphorylation events can affect the stability of β-catenin interactions with both cadherin and 
α-catenin (Kim et al. 2011; Chen et al. 2016). Phosphorylation of the catenin-binding-domain 
(CBD) of E-cadherin stabilizes its interaction with β-catenin (Aberle et al. 1994; Yap et al. 1998). 
Unphosphorylated cytoplasmic domain conversely has lower binding affinity to β-catenin. On the 
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other hand, phosphorylation of β-catenin by Src kinase at Tyr 654 disrupts its binding to E-
cadherin cytoplasmic domain (Roura et al. 1999). 
α-catenin 
Cadherin is indirectly associated with α-catenin via β-catenin. α-catenin is an actin binding protein 
that regulates F-actin by its association with the actin regulatory protein (Arp 2/3 complex) 
responsible for actin filament branching (Nagafuchi et al. 1991; Kovacs et al. 2002; Drees et al. 
2005). Despite the indirect association, α-catenin is affected by cadherin mediated intercellular 
adhesion. Recent studies revealed that α-catenin is the mechanical tension sensor at cadherin 
junctions and responds to forces across the cadherin-catenin-actin chain. At low tension, the a-
catenin is auto-inhibited, but high tension triggers a conformational change, to expose a vinculin 
binding site, which recruits vinculin to cadherin adhesions at the plasma membrane (Yonemura et 
al. 2010; Twiss et al. 2012; Barry et al. 2014; Maki et al. 2016). In this context, catenin acts as 
a force sensor at cell-cell junctions. 
p120 catenin 
p120 catenin, initially recognized as an important Src kinase substrate (Reynolds et al. 1992), was 
subsequently found to interact with the cytoplasmic domain of cadherin. p120 catenin specifically 
interacts with 93 amino acids in the juxtamembrane domain (JMD) located between the 
transmembrane domain and the β-catenin-binding domain of cadherin (Miranda et al. 2003; 
Hartsock and Nelson 2012; Ishiyama and Ikura 2012). P120 catenin is well known to affect 
cadherin adhesion, by regulating cadherin stability at the plasma membrane. The p120ctn binding 
interface of classical cadherins contains an acidic tripeptide ubiquination sequence DEE, which is 
encrypted when p120ctn is bound (Davis et al., 2003). The downregulation of p120 catenin results 
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in cadherin internalization. In addition, the interaction between p120 catenin and the cadherin 
cytoplasmic domain is regulated by phosphorylation, which reduces the catenin binding affinity, 
to trigger cadherin internalization and reduce adhesion (Fukumoto et al. 2008). For example, 
tyrosine phosphorylation of E-cadherin at Y755/756 or VE-cadherin at Y658 disrupts p120 
binding (Fukumoto et al. 2008). However, numerous phosphorylation sites have been identified 
within both the N-terminal and C-terminal domains of p120 catenin, but the functional 
consequences of each site are still being determined (Mariner et al. 2001; Xia et al. 2003). In 
addition to regulating p120 catenin binding to cadherin, the N-terminal site of p120 catenin recruit 
the Rho family GTPase activating proteins (RhoGAP) to cell-cell junctions upon E-cadherin 
ligation (Anastasiadis et al. 2000; Dohn et al. 2009).   
1.5. The Disconnect: How do Cadherin Extracellular Interactions and 
Intracellular Response Via Cytoplasmic Domain Correlate? 
Section 1.3 described the interactions by which cadherin ectodomains bind and how 
conformations, structural perturbations, or posttranslational modifications within the ectodomain 
regulate cadherin binding either in solution or between lipid bilayers. The majority of the studies 
done did not take the cytoplasmic regulation into consideration. Conversely, in all the regulatory 
activities described in section 1.4, it is clear that cadherin mediated homophilic adhesion signals 
to its intracellular binding proteins and regulates the process of adhesion and signaling. However, 
the most important phenomenon in the regulation of cell adhesion is that it requires the breaking 
and reforming of homophilic adhesive bonds. Even regulatory processes like internalization and 
trafficking require the controlled disruption of homophilic cadherin bonds between neighboring 
cells.  
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Although much has been learned about these signaling pathways, catenins, and cytoskeletal 
proteins that affect adhesion, the mechanisms by which they regulate homophilic cadherin binding 
on the cell surface are still unknown. This differs from the regulation of integrin-mediated 
adhesion, for which it is known that conformational changes in the extracellular domain and 
associated changes in clustering and ligand binding affinity are controlled by associated 
cytoplasmic proteins such as talin and kindlins in response to signaling events (Hynes, 2002; 
Ginsberg et al., 2005; Shattil et al., 2010). This is due to the lack of experimental systems that can 
probe changes in cadherin binding activity at cell-cell junctions. One such experimental system 
that enabled us to address this disconnect was E-cadherin expressing Colo 205 adenocarcinoma 
cells that could be specifically activated for E-cadherin mediated adhesion. This could be achieved 
by using activating monoclonal antibodies that seemed to work by triggering inside-out signaling 
through p120 catenin dephosphorylation, and resulting in phenotypic differences between the 
activated and the inactive states of Colo 205 cells (Petrova et al. 2012; Shashikanth et al. 2015; 
Maiden et al. 2016). This provided first support to an inside-out allosteric regulation model, where 
the cadherin cytoplasmic domain interactions actually affected the ectodomain activity. 
Quantitative affinity measurements proved this inside-out allosteric regulation hypothesis, which 
is the core of chapter 4 of this thesis. 
1.6 Questions addressed in this thesis 
The goal of the research described in this thesis is to investigate the regulation of cadherin 
homophilic adhesion by both its ectodomain and the cytoplasmic domain, and importantly, to find 
the correlation between each other. The questions addressed in this thesis are: 
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a) Are cadherin binding affinity and kinetics allosterically modified by its cytoplasmic 
domain binding partners –α-catenin (Chapter 2) and p120 catenin (Chapter 3)? 
b) What effect do putative lateral interaction mutants have on the binding, and what are the 
functional implications for cell-cell adhesion? (Chapter 4) and  
c) What is the impact of N-glycosylation and O-mannosylation of E-cadherin on its 
interactions at cell-cell junctions? (Chapter 5) 
Results described in this thesis led to the first quantitative demonstration that E-cadherin binding 
activity is allosterically regulated by inside-out signaling by p120 catenin dephosphorylation. The 
impact of a putative cis-interface was inferred to indeed affect cis interactions between cadherins 
and could dictate its function. Studies with N-glycosylation mutants and O-mannosylation 
deficient cell lines expressing E-cadherin made an unusual discovery that glycosylation can 
sometimes be beneficial for adhesion, depending upon its orientation on the cadherin ectodomain, 
and that the kinetic signatures again were strongly correlated with the functional perturbations 
observed. 
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 1.7 Figures 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Crystal Structure of C-cadherin and strand swap dimerization (adapted from 
(Boggon 2002). (A) Stereo view of the C-cadherin ectodomain. Trp2 is shown in CPK 
representation and colored purple; green spheres, calcium ions; cyan, disulfide bonds; red, O-
linked sugars; blue, N-linked sugars. Individual cadherin-like domains are labeled EC1 through 
EC5. (B) Detailed stereo view of the strand dimer interaction. Side chains that make direct contact 
with the partner molecule are labeled, and a water molecule that mediates the Asp1-Asp1 
interaction is shown. 
A 
B 
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Figure 1.2. Model of the cadherin–catenin cell adhesion complex (adapted from (Ishiyama 
and Ikura 2012)). The cadherin–catenin cell–cell adhesion complex consists of E-cadherin (PDB 
code 3Q2V), p120-catenin (PDB code 3L6X), β-catenin (PDB code 1I7W) and α-catenin (PDB 
codes 1DOW & 1H6G). α -catenin could either directly interact with F-actin (PDB code 3B63) or 
indirectly via vinculin (PDB code 1ST6) or other actin-binding molecules (adapted from Ishiyama 
and Ikura 2012). 
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Figure 1.3. X-dimer interface with residues showing relaxation dispersion NMR highlighted 
by stick representation (Li et al. 2013). EC 1- EC2 interface showing the prominent residues 
involved in the X-dimer interaction. The green spheres represent bound calcium.  
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Figure 1.4. Stereo views of cis interfaces observed in crystal structures of mouse E-cadherin 
(adapted from (Harrison 2011)). Interfaces are formed between a concave surface of EC1 
(salmon) and a convex surface of EC2 of a partner molecule oriented in parallel (blue). Regions 
of EC3 involved in contacts are also shown. Side chains of residues contributing at least 10Å2 
buried surface area to the interface are displayed as sticks. Hydrogen bonds are shown as dashed 
lines, calcium ions are shown as green spheres. Residues which were mutated are represented in 
magenta (Chapter 3). 
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CHAPTER 2  
Adhesion Frequency Measurements Of Cadherin 
Kinetics 
Sub-section 2.3.3 is part of an article published in the Journal of Cell Science, and is being 
reproduced after obtaining due permission. [Reference: Barry AK, Tabdili H, Muhamed I, Wu J, 
Shashikanth N, Gomez GA, Yap AS, Gottardi CJ, de Rooij J, Wang N et al. 2014a. alpha-catenin 
cytomechanics-role in cadherin-dependent adhesion and mechanotransduction. J Cell Sci 127: 
1779-1791.] 
 
2.1 Introduction 
Measurements of the adhesion frequency between cell pairs were used to quantify the two 
dimensional affinities and dissociation rates of classical cadherins. Micropipette measurements 
have been used to determine the two-dimensional affinities and dissociation rates of adhesion 
protein receptors including cadherins and selectins, in the context of the cell membrane (Chesla et 
al. 1998; Chesla et al. 2000; Huang et al. 2007; Chien et al. 2008; Jiang et al. 2011). In these 
adhesion frequency measurements, cell pairs are repetitively brought into contact for defined time 
intervals. Explicitly, one cell expressing a protein of interest on its surface, is partially aspirated 
into a micropipette (Fig 2.1). A red blood cell (RBC) that has been chemically modified with the 
ligand or receptor of interest, is partially aspirated into a second micropipette. The two cells are 
then repeatedly brought into contact, at a defined contact area and time interval, and then retracted. 
If the cells adhere, the RBC deforms slightly and recoils upon bond rupture, as detected from 
dynamic imaging during the measurements. The measurements quantify the binding probability, 
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P, which is the number of times binding (i.e., deformation of the RBC at withdrawal) events are 
observed (nb) divided by the total number of contact cycles (NT). The contact time between the 
two cells is controlled, and the time evolution of the binding probability reflects the protein 
densities and the binding mechanism.  
2.2 Materials and Methods 
The process used to prepare cells for adhesion measurements is outlined below and described in 
detail in this chapter: 
1. Drawing whole blood from healthy volunteers and isolation of RBCs from the whole blood. 
2. Labeling RBCs with a specific antibody that can bind to protein tags like hexahistidine or 
IgG-Fc. These tags are expressed as the end segments of adhesion protein ectodomain, so 
they can bind to the antibodies and orient themselves on the RBCs. 
3. Quantification of surface densities of adhesion protein receptors on both the labeled RBCs, 
and the cell line of interest, which is expressing the desired adhesion protein. This is 
accomplished by performing flow cytometry on stained single cells and quantification 
using calibration kits. 
4. Performing test cell- RBC micropipette adhesion frequency measurements and obtain 
binding frequency data w.r.t. contact time. 
5. Qualitative and quantitative analysis of the binding frequency curve including parsing 
between two phases of binding (observed with WT cadherins) and fitting data appropriately 
to receptor-ligand binding equations to obtain equilibrium and kinetic parameters. 
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2.2.1 Isolation of Red Blood Cells from Whole Human Blood 
Human red blood cells were isolated and modified according to the approved Institutional Review 
Board at the University of Illinois Urbana-Champaign under protocol # 08669. First, 20mL of 
whole blood was drawn from healthy volunteers by informed consent, by trained phlebotomists at 
the Community Blood Services of Illinois (CBSI). This blood was stored and transported in purple-
top “VacutainerTM” vials (coated with EDTA to prevent coagulation) to a Biosafety Level II 
certified cell culture hood. Red Blood Cells (RBCs) were then isolated from the human whole 
blood using Histopaque 1119 (Sigma-Aldrich, St Louis, MO), following the manufacturer’s 
protocol. A 12 ml aliquot of Histopaque 1119 was taken in a 50 ml centrifuge tube. Then 8 ml 
whole blood and 7 ml of 0.9 w/v% NaCl were mixed, and slowly transferred to the tube containing 
Histopaque. The mixture was centrifuged at 1200 g (rcf) for 20 minutes at room temperature in an 
Eppendorf 5810R bench top centrifuge (Fig 2.2). The supernatant was discarded as biological 
waste, and the remaining cells were re-suspended in 6 ml of 0.9 % w/v NaCl, prior to the addition 
of 2 ml of 6 % w/v Dextran, to obtain a final concentration of 1.5% w/v. The cells were incubated 
at room temperature for 45 minutes, during which they settled to the bottom of the tube. After 
discarding the supernatant, the red blood cells (RBC) were washed twice at room temperature with 
0.9 w/v% NaCl, and re-suspended in 15 ml EAS45 (2.0 mM Adenine, 110.0 mM Dextrose, 55.0 
mM Mannitol, 50.0 mM NaCl, 10.0 mM glutamine and 20.0 mM Na2HPO4, at pH 8.0). The 
purified RBC suspension in EAS45 was stored at 4°C (Fig 2.2), and was used for up to 3 months, 
after which the RBC suspension was treated with 10% bleach for 15 min and discarded. 
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2.2.2 Surface Modification of RBCs with Cadherin Extracellular Domains 
Anti-Fc antibodies covalently bound to the RBC surface were used to capture the Fc-tagged 
cadherin ectodomains. Antibodies were covalently coupled to the RBCs, using the chromium 
chloride coupling method (Gold and Fudenberg 1967; Kofler and Wick 1977). Either goat 
polyclonal anti-human immunoglobin G (IgG) Fc antibody (Sigma-Aldrich, St Louis, MO) or 
mouse monoclonal anti-6X-His antibody (Aviva Systems Biology, San Diego, CA) was used to 
capture and orient Fc-tagged or 6X-Histidine tagged cadherin ectodomains.  
A CrCl3 solution was serially diluted to concentrations below 0.01 w/v% with 0.02 mM sodium 
acetate, containing 0.85 w/v% NaCl. In order to chemically activate RBCs for the covalent 
immobilization of antibody to glycoproteins on RBCs, 250 µl of diluted CrCl3 solution was mixed 
with 250 µl of the red blood cell/antibody mixture, and incubated at room temperature for 5 
minutes. The reaction was stopped with 500 µl of ‘stop solution’ (PBS with 5 mM EDTA and 1% 
BSA). The cells were then washed twice with the stop solution. The concentration of CrCl3 
determined the density of antibodies immobilized to the surface of the RBCs. Treating the RBCs 
with different CrCl3 concentrations achieved the desired antibody surface density. 
2.2.3. Quantification of Cadherin Surface Expression Levels 
Flow cytometry measurements quantified the density of surface-bound cadherin (cadherins/µm2). 
E-cadherin expressing cells were labeled with the primary, anti-E-cadherin antibody DECMA-1 
(Sigma-Aldrich, St. Louis, MO), which binds the fifth extracellular repeat domain (EC5) of murine 
and human E-cadherin (Vestweber and Kemler 1985; Ozawa et al. 1990). The secondary antibody 
was CFL-647 - conjugated anti-rat IgG (whole antibody, Santa Cruz Biotech, TX). The antibody 
labeling was done in 1X PBS containing 1 % w/v BSA at pH 7.4. The fluorescence intensities of 
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labeled cells were measured with an LSR II flow cytometer (BD Biosciences). The calibration 
curve used to relate the fluorescence intensity to the cadherin surface density was generated with 
calibrated Alexa 647-labeled standard beads (Bangs Laboratories, Fishers, IN) (Fig 2.3).  
2.2.4. Micropipette Measurements of Cell Binding Kinetics  
Adhesion frequency measurements quantified the intercellular binding probability as a function of 
contact time, by using opposing micropipettes to manipulate interacting cell pairs (Fig 2.1) 
(Shashikanth et al. 2016). The measured binding probability P(t) is the ratio of the number of 
binding events nb to the total NT cell-cell touches, nb/NT, and is a function of the number of cell-
to-cell bonds (Chesla et al. 1998b). In these measurements, a cadherin-expressing cell and a RBC 
with surface-bound, His6-tagged (or Fc-tagged) cadherin ectodomains were partially aspirated into 
opposing glass micropipettes (Figs. 2.1A, B). The experimental chamber contained L15 medium 
(Invitrogen, Carlsbad, CA) supplemented with 1 w/v% BSA and 2mM CaCl2, and diluted 1:1 with 
deionized water. This hypo-osmotic solution keeps the RBCs rounded.  Cells were observed with 
a 100x oil immersion objective on a Zeiss Axiovert 200 microscope, and images were recorded 
with a Manta G201B camera (AVT technologies) interfaced with a high resolution (1080 x 720 
pixels), flat screen monitor. 
The contact time was manipulated with computer-controlled, piezo-electric manipulators 
that were programmed to repeatedly bring the two cells into contact for defined intervals. The 
visualized contact area was controlled at 6 ± 1 µm2 during a single set of measurements. Binding 
events were identified from surface deformations of the RBCs during cell separation and the recoil 
at bond rupture. Each cell pair was tested for 50 repetitive cell-cell touches (NT = 50), and each 
contact time in the figure represents measurements with at least three different cell pairs (Fig 2.4). 
The mean and standard deviation of each set of 50 tests was determined from the Bernoulli 
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distribution. The probabilities P at each time point shown in the graphs are the average of 
measurements with 3 cell pairs, and the error bars indicate the standard errors from the mean of 
the 3 sets of measurements with different cell pairs (Fig 2.5).  
2.2.5. Analysis Of Binding Frequency Data 
Micropipette data format 
The data originally obtained from the micropipette experiment was a series of ‘1’ and ‘0’ which 
corresponded to adhesive or non-adhesive cell-cell contacts, respectively. Three sets of data were 
taken for each time point, with 50 cell-cell touches per cell pair. First, for each data set, the binding 
probability was calculated by dividing the observed number of adhesion events by the total number 
of cell-cell contacts. The total probability of observing adhesion can be represented as the sum of 
the probability of forming one or more bonds. To represent that mathematically in a simplified 
manner, it is defined as 1-P0, where P0 is the probability of forming zero bonds. From the range of 
binding probabilities used in the experiments (0 < P < 0.8), it can be inferred that the number of 
bonds formed is small, and likely single digits (Chesla et al. 1998).  
The Poisson probability function closely matches the full solution to the master equation 
under these conditions (Chesla et al. 1998). With this assumption, the number of bonds formed in 
the contact site for each time cell-cell contact time is sampled, and therefore, the number of 
observed adhesion events follows a Poisson distribution centered on the mean number of bonds in 
the contact area. This results in a mathematical expression that relates the average number of bonds 
in the contact area <n> to the binding probability P(t) (Chesla et al. 1998). The initial binding step 
due to trans (adhesive) cadherin bond formation can be described by a simple receptor (R) -ligand 
(L) binding reaction : 
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                                                        Reaction 2.1 
Where the binding and dissociation rates are kon and koff, respectively. The analytical expression 
for the time-dependent, binding probability P (t) for the above reaction is:  
𝑷(𝒕) = 𝟏 − 𝒆𝒙𝒑 {− [𝒎𝑹𝒎𝑳𝑨𝒄𝑲𝟐𝑫 (𝟏 − 𝒆𝒙𝒑(−𝒌𝒐𝒇𝒇𝒕))]}              Equation 2.1 
Here, mL and mR are the receptor and ligand surface densities (cadherins/µm
2) on the two cells, Ac 
is the contact area (µm2), K2D is the two-dimensional binding affinity (µm
2), and koff is the 
dissociation rate (s-1). The values of the ligand surface densities and contact areas (cadherins/µm2) 
were known. Thus, the two-dimensional affinity K2D and off rate koff for trans-binding were 
estimated from fits of Equation 2.1 to the data corresponding to the first binding step—that is, the 
rise to P1 (Chien et al. 2008; Langer et al. 2012; Tabdili et al. 2012; Shashikanth et al. 2015) 
Estimation of variation in the data 
To estimate the standard deviation of the data for error analysis, the binding probability was first 
assumed to follow a binomial function, because each contact cycle generated a one or a zero. The 
variance of a binomial distribution depends on the number of trials and on the mean probability 
(Equation 2.2). This standard deviation was used to determine the weighting factor for the least 
squares regression used to estimate the receptor-ligand binding parameters. 
𝜎2 = 𝑁𝑝(1 − 𝑝)                                     Equation 2.2 
Weighted non-linear least squares regression 
To determine the best-fit parameters for the first cadherin-cadherin binding phase (Chapter 1, 
Section 1.3.2), the data were fit to the kinetic model for simple receptor-ligand binding (Equation 
R+ L
koff
kon
«RL
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2.1), using weighted non-linear least squares regression. The non-linear regression was performed 
in OriginPro 10.0 (OriginLab, Northampton, MA) using their non-linear analysis tool. Equation 
2.1, the simple binding mechanism, was programmed as a user equation in the non-linear least 
squares analysis tool. The binding probabilities at different time points were entered. Because of 
the spread in the variation, a weighted non-linear least squares regression was performed, using 
the calculated variance given by Equation 2.2. Each data point was weighted by the inverse of its 
variance, so that the greatest weights were given to the data points with the least variability. The 
best fit kinetic parameters were calculated, using the non-linear analysis tool, the weighting 
factors, and the input of Equation 2.1. After thus estimating the parameters Ka and koff, a lack of 
fit test was used for validation of the model fit to the given data. 
Parsing the two phases of adhesion frequency time courses 
To determine the kinetic data that were described by the model, we used a non-linear lack of fit 
test for a system with repeated observations (Neill 1988). The test utilizes the multiple 
measurements at each time point, and compares the intrinsic variability in the data to the residuals 
between the data and the proposed model (Equation 2.2). The test statistic follows an F-distribution 
(Equation 2.3).  
The null hypothesis for this test is that the model describes the data, so the calculated 
statistic exceeds the critical F-value when the model is no longer valid. For each experiment, the 
kinetic parameters for the first phase were estimated using non-linear least squares regression, 
followed by testing for lack of fit using the statistic in Equation 2.3 to determine if those time 
points were associated with the first phase. The parameters reported for the first phase are those 
for the maximum number of points which could fall under the critical F-value. 
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        𝐹 =  
∑ {𝑛𝑖(?̅?𝑖 − ?̂?𝑖)^2|(𝑛 − 2)}
𝑛
𝑖=1
∑ ∑ {(𝑦𝑖𝑗 − ?̅?𝑖)^2|(𝑁 − 𝑛)}
𝑛𝑖
𝑗=1
𝑛
𝑖=1
                                   Equation 2.3 
For this test statistic, n is the number of distinct time points observed, ni is the number of 
observations at each time point, means the average value of observations at time point i, refers to 
the model prediction at time point i, refers to each individual measurement, and N is the total 
number of observations. 
2.3 Results- Example of Classical Cadherins 
2.3.1 Classical Cadherin Binding Kinetics is Biphasic 
The binding time course of the binding probability measured between chicken N-cadherin 
extracellular domains was characterized using the micropipette adhesion frequency assay. For the 
test cell surface, N-cadherin was expressed in CHOK1 cells, and a construct of the N-cadherin 
extracellular region attached to an Fc tag was immobilized on a RBC. The binding probability 
curve exhibited two phases: First,  an initial, fast rise (1-2 s) to a plateau that lasted ~3-5s, and then 
a second rise to a final binding probability (5-20 s) (Fig 2.6). This signature is consistently 
observed with most classical cadherins studied- Epithelial (E)- cadherin, Neural (N)- cadherin and 
Cleavage stage (C)- cadherin (Chien et al. 2008; Langer et al. 2012; Shashikanth et al. 2016). The 
two dimensional affinity and off rates were determined from non-linear least squares fits of the 
data to the receptor-ligand binding model in Equation 2.1. Parsing the second phase from the first 
phase was done using the F-test as described above. 
2.3.2 Testing the influence of α-catenin on E-cadherin affinity 
As described in Chapter 1, classical E-cadherin adhesive junctions comprise E-cadherin, 
and its cytosolic binding partners, catenins. The cadherin is linked to the actin cytoskeletal 
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framework via catenins. β-catenin binds the cytoplasmic binding domain of cadherin, and the actin 
binding protein α-catenin is the molecular bridge between β-catenin and actin (Gumbiner 2005).  
Based on antibody binding studies and domain mapping of α-catenin, Yonemura et al. 
(Yonemura et al. 2010) postulated that force triggers the exposure of a cryptic vinculin-binding-
site in α-catenin that in turn recruits vinculin and actin to cadherin junctions. The latter findings 
suggest that catenin functions as a mechanotransducer. Relevant to this, further studies showed 
that α-catenin regulates cadherin-mediated adhesions in different mechanical contexts (Barry et al. 
2014; Kim et al. 2015). However, the influence of α-catenin on cadherin-mediated 
mechanotransduction could also involve inside-out modulation of cadherin binding-affinity and 
cadherin-mediated cell-cell adhesion.  
To test whether catenin allosterically altered the cadherin binding affinity, I performed 
micropipette measurements to quantify the effect of α-catenin on the intrinsic two-dimensional E-
cadherin affinity, in the native context of the cell membrane, by comparing the affinities of E-
cadherin expressed on Madine Darby Canine Kidney (MDCK) cells. MDCK cells in which WT 
α-catenin was knocked down (KD) by expressing a short hairpin shRNA. These cells were then 
rescued with GFP-tagged mouse α-catenin (MDCK rescued cells).  
In these measurements, an MDCK cell expressing full-length E-cadherin was repetitively 
brought into contact with a red blood cell (RBC) that was modified with oriented E-cadherin-Fc. 
Fig 2.7 shows the binding probability P as a function of contact time between the modified E-cad-
Fc RBCs and either MDCK KD or MDCK Rescued cells. The two-stage kinetic profile observed 
with both cell types is similar to previously reported cadherin-binding kinetics (Fig 2.6) (Chien et 
al. 2008; Tabdili et al. 2012). A fast rise to an initial plateau at P1 ∼0.51 (MDCK KD) is followed 
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by a 2–4 s lag and a slower rise to a steady-state probability at P2 ∼0.8 after ∼20 s. The density of 
E-cad-Fc on the RBCs was 29 cadherins/µm2, and the E-cadherin densities on the MDCK Rescued 
and MDCK KD cells were 40 and 44 cadherins/µm2, respectively, as determined by flow 
cytometry (Barry et al. 2014). The best-fit, two-dimensional affinity and dissociation rate for E-
cadherin on MDCK Rescued cells were (1.82±0.23) ×10−4 µm2 and 0.86±0.15 s−1 (mean ± s.e.m.), 
respectively. With α-catenin KD cells, the best-fit affinity and dissociation rate were (1.29±0.17) 
×10−4 µm2 and 1.2±0.18 s−1. The affinities appear different, but the difference is insignificant at 
the 95% confidence level (P = 0.07). These results suggest that α-catenin has negligible effect on 
the cadherin affinity. 
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2.4 Figures 
 
Figure 2.1. Illustration of the micropipette configuration used in binding probability 
measurements. (a) A test cell (for example, MDCK cells) expressing full-length cadherin is 
aspirated into the left micropipette, and a Red Blood Cell (RBC) ectopically modified with E-Cad-
His6 (or E-Cad-Fc) is aspirated into the right micropipette (see illustration in (b)). The cells are 
repetitively brought into contact for a defined time interval (and contact area) and separated with 
computer-controlled, piezoelectric manipulators. Adhesion events are quantified from visible RBC 
deformations and recoil upon bond failure. In the left micropipette, cells can be replaced with a 
modified RBC, as in the right pipette, in order to quantify binding between ectodomains only.  
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Figure 2.2 Isolation of red blood cells (RBCs). Whole blood was mixed with a gradient maker 
(Histopaque 1118) and centrifuged to yield the components of blood as shown to the left. Only the 
RBCs were preserved. The rest was treated with 10% bleach for 10 min and discarded. After two 
washes with 0.9% NaCl, the RBCs were finally suspended in Erythrocyte storage Buffer EAS-45, 
as shown in the right image, and stored at 4 °C. 
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Figure 2.3: Calibration and quantification of the surface density of cadherins, using flow 
cytometry. The calibration curve is obtained by plotting the median intensity determined with 
five, standard fluorescent bead populations, each with a known amount of embedded Alexa-647 
fluorophore. The excel sheet template is provided by the calibration bead company, Bangs 
Laboratories Inc. The molecules of equivalent soluble fluorochrome (MESF) values are 
approximately the number of antibodies, which can be converted into surface density 
(cadherins/area) by dividing MESF by the estimated surface area of the cell or bead used for the 
analysis.  
HaCaT surface area 1133.54 um2 Date 3/9/2016
Sample Channel MESF Difference Density Round off
Ctrl Hacat 1 83 6207 0 0
Ctrl Hacat 2 84 6287 0 0
0.5 ul AK23 569 48643 42456 37.45435
1.0 ul AK23 571 48825 42638 37.61491 37.73643
1.5 uL AK 23 581 49740 43553 38.42211
2.0 uL AK 23 569 48643 42456 37.45435
Density = Difference/surface area
For Anti-Fc tagged antibodies, Density = 2* difference/surface area
Method: Primary Dsg3 binding antibody AK23
Secondary antibody labeling goat Anti-mouse Alexa 647 IgG
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Figure 2.4 Cadherin-mediated binding probability versus contact time obtained from 
repetitive cell-cell touches between E-cadherin expressing MDCK cells and E-cad-Fc 
labeled RBCs. Each point in this graph represents an average binding probability (ratio of the 
number of binding events nb to the total NT cell-cell touches) obtained from at least 50 (=NT) 
cell-cell touches. There are three such points obtained for each contact time (typically at 0.5, 1, 
2, 3, 4, 5, 7, 10, 12, 15, 20 (and if required) 30 and 40 s). The three sets of points depicting the 
whole curve are colored distinctly for spotting the variation in probability distribution for each 
contact time. 
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Figure 2.5 Binding probability versus contact time with model fit. This plot indicates the 
binding probability measured between RBCs labeled with E-Cad-Fc, in the presence of 19A11 Fab 
fragments. Each data point is the average of the three independent determinations of the binding 
probability (P) for each contact time, and the error bar is the standard error of the mean (Equation 
2.2). The first rise to the first plateau, corresponding to trans dimerization (see Chapter 1) is fitted, 
by non-linear, least squares regression, to the model (solid black line) (Equation 2.1), in order to 
obtain the best fit binding parameters K2D and koff. 
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Figure 2.6. Binding probability versus contact time measured between CHO cells expressing 
human N-Cadherin and RBCs modified with mouse N-cad-Fc (adapted from Matthew 
Langer- PhD thesis 2012): In this figure, Binding probability versus contact time between CHO 
cell expressing wild type human N-Cad and a RBC modified with N-Cad-Fc is shown as an 
example. There is an initial rise in the first 2s, followed by a lag for ~5s, and then a second increase 
in the binding probability. The first phase is due to trans binding between cadherin ectodomains, 
and the data are fit to the model to obtain the binding parameters (K2D and koff). The dotted lines 
are the 95% confidence intervals for the model parameters thus obtained. The possible mechanism 
underlying the second rise in probability is discussed in Chapter 4. 
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Figure 2.7 α-catenin does not significantly alter the cadherin binding kinetics. The data show 
the binding probability versus cell–cell contact time measured between RBCs modified with E-
cad-Fc and MDCK α-catenin KD cells (black squares) or MDCK α-catenin Rescued cells (white 
squares). The solid line is the nonlinear least squares fit of Equation 2.1 to data for the first binding 
step, measured with MDCK Rescued cells, with best-fit parameters given in the Section 2.3 of the 
text. The dotted line is the fit to data obtained with MDCK KD cells, with best-fit parameters given 
in the text. The dashed line indicates the limiting binding probability P2 determined with both 
MDCK Rescued and MDCK KD cells. Control data (white circles) were measured between 
MDCK Rescued cells and RBCs modified with anti-human IgG (Fc) antibody without bound E-
cad-Fc. 
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CHAPTER 3  
Allosteric regulation of cadherin adhesion 
This chapter has been reformatted from its published version in the Journal of Biological 
Chemistry (JBC). [Reference: Shashikanth N, Petrova YI, Park S, Chekan J, Maiden S, Spano M, 
Ha T, Gumbiner BM, Leckband DE. 2015. Allosteric Regulation of E-Cadherin Adhesion. J Biol 
Chem 290: 21749-21761]. 
 
3.1 Introduction 
Intercellular interactions are not static, and many critical biological processes such as collective 
migration (Ciesiolka et al. 2004; Weber et al. 2012) or endothelial barrier disruption during 
leukocyte extravasation (Wessel et al. 2014) require dynamic cadherin regulation for facile cell 
detachment and reorganization.  Adhesion strength is a function of E-cadherin affinity and surface 
expression, which is under transcriptional control and modulated by trafficking and endocytosis 
(Gumbiner 2005).  Mechanical factors such as the stiffness of the cell cortex or increased 
cytoskeletal interactions can influence adhesion strength (Evans and Calderwood 2007; Manning 
et al. 2010; Maitre et al. 2012). Additional evidence suggests that inside-out signaling may also 
allosterically regulate E-cadherin adhesive activity (Aono et al. 1999; Zhong et al. 1999; Gumbiner 
2005; Chen et al. 2009; Petrova et al. 2012). 
Inside-out/outside-in signaling typically involves allosteric coupling between binding sites 
and distal effector sites on opposite sides of the membrane (Motlagh et al. 2014). Thus, altered 
cadherin binding caused by perturbations at sites away from the homophilic binding site would 
evince the allosteric regulation of cadherin adhesion.  For example, cytoplasmic perturbations alter 
both integrin adhesion and clustering (Lu et al. 2001; Vorup-Jensen et al. 2003; Luo et al. 2004).  
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Although cadherins are transmembrane proteins, studies of cadherin binding mechanisms have 
largely focused on active recombinant extracellular domains (Shapiro and Weis 2009).  
Circumstantial evidence for the allosteric regulation of cadherins includes the modulation 
of cadherin adhesion upon association with other membrane proteins, such as protocadherins 
(Chen and Gumbiner 2006; Chen et al. 2009; Emond et al. 2011). Additionally, point mutations 
and antibody binding at epitopes away from the N-terminal binding-site abrogated adhesion 
(Ozawa et al. 1990; Berx et al. 1998; Prakasam et al. 2006).  Conversely, the binding site mutation 
W2A altered epitope exposure in an ectodomain region near the membrane (Tsuiji et al. 2007).    
E-cadherin specific monoclonal antibodies (mAbs) were recently shown to activate the E-
cadherin-mediated aggregation of Colo 205 cells (Petrova et al. 2012). Colo 205 cells express E-
cadherin but do not aggregate unless treated with trypsin or the kinase inhibitor staurosporine 
(Aono et al. 1999).  The activating antibodies triggered Colo 205 aggregation and tight cell 
compaction, and also decreased the phosphorylation of p120 catenin, a cytoplasmic protein that 
binds the cadherin cytodomain (Shapiro and Weis 2009). Conversely, the expression of a 
phosphorylation deficient p120 catenin mutant constitutively stimulated Colo 205 cell aggregation 
(Petrova et al. 2012).  
The strengthening of cadherin-mediated intercellular adhesion has been attributed to 
several mechanisms including GTPase activity (Kaibuchi et al. 1999; Chu 2004; Waschke et al. 
2004; Kardash et al. 2010; Daneshjou et al. 2015), enhanced cadherin-cytoskeletal interactions 
(Nagafuchi et al. 1994; Nelson 2008; Maitre et al. 2012; Thomas et al. 2013; Barry et al. 2014), 
cadherin catch bonds (Rakshit et al. 2012), cadherin clustering (Yap et al. 1997; Wu et al. 2011; 
Hong et al. 2013), and altered cortical tension (Manning et al. 2010; Maitre et al. 2012).  
Demonstrating that Colo 205 aggregation was caused by the allosteric regulation of E-cadherin 
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required demonstrating that specific perturbations, which do not affect the binding site directly, 
caused quantitative changes in the E-cadherin affinity. 
In this chapter, micropipette intercellular adhesion frequency measurements (Chesla et al. 
1998) were used to quantify the binding kinetics and two-dimensional affinity of full-length E-
cadherin expressed on Colo 205 cells.  The results demonstrated that four different treatments that 
altered p120 catenin phosphorylation had quantitatively similar effects on the E-cadherin-mediated 
binding kinetics of Colo 205 cells, increasing the E-cadherin binding affinity ~3 fold. Super 
resolution imaging confirmed that these treatments did not alter the size distributions of E-cadherin 
clusters, at the resolution of the measurements. These results thus provide direct biophysical 
evidence for the allosteric regulation of E-cadherin adhesive function.        
3.2 Materials and Methods  
Note: The Red Blood Cell isolation, labeling, and the entire micropipette procedure and analysis 
is detailed in Chapter 2 dedicated for this purpose. 
3.2.1 Plasmids, Cell Lines and Antibodies 
All cell lines used were from the American Type Culture Collection (Manassas, VA). Cells were 
cultured in Dulbecco’s Minimum Eagle Medium (DMEM) containing 10% fetal bovine serum 
(FBS) (Life Technologies, Carlsbad, CA) in a 5% CO2 atmosphere at 37°C. The activating 
antibody 19A11 (Whole and Fab fragments) and the neutral antibody 76D5 (Whole and Fab 
fragments), as well as the generation of Colo 205 cells infected with mouse p120 catenin retroviral 
constructs were described previously (Petrova 2012). Inhibitory antibody rat uvomorulin anti-E-
cadherin IgG (DECMA-1 clone) was purchased from Sigma-Aldrich, St Louis, MO. 
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3.2.2 Retroviral Constructs 
Note: The cell lines with these constructs were obtained from Dr. Yuliya Petrova with Prof Barry 
Gumbiner (Petrova et al. 2012) 
Retroviral constructs including pLZRS Neo (empty vector), mouse p120 catenin isoform 3A wild 
type and 6S, T→A mutant (Ireton et al. 2002; Xia et al. 2006) were a generous gift from Albert 
Reynolds (Vanderbilt University). The 6S, T→A mutant harbors S252A, S268A, S288A, T310A, 
S312A and T916A mutations. Virus production was described previously (Ireton et al. 2002; Xia 
et al. 2006). Colo 205 cells were infected with respective retroviruses by spinoculation in 6-well 
tissue culture plates at 1800g for 2h at 33°C, and selected with 1mg/ml Neomycin for 10 days. 
Mock-treated cells were infected with retrovirus containing the empty vector (Neo), and subjected 
to the same selection protocol as the other lines. Mouse p120 catenin expression levels were 
estimated by Western blot analysis (not shown), using mouse p120-specific mAb 8D11 (Wu et al. 
1998) (from Albert Reynolds). Immunofluorescence imaging was done with cells stained with 
human E-cadherin extracellular domain-specific IgG2b mAb 27D2, together with mouse p120 
catenin-specific IgG2a mAb 8D11. As secondary, goat-anti-mouse IgG2b-Alexa488 (A21141) 
and IgG2a-Alexa546 (A21133) (both from Invitrogen) were used. Immunofluorescence images 
were acquired using IX-71 fluorescent microscope (Olympus), LUCPlanFL N 20x objective lens, 
digital CCD Camera C10600-10B (Hamamatsu) and SlideBook 5.0 Software (Intelligent Imaging 
Innovations, Inc.). 
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3.2.3 Treatment Of Red Blood Cells With E-Cadherin Ectodomains And With Anti-E-
Cadherin Antibodies 
C-terminal Fc-tagged or hexahistidine-tagged E-cadherin ectodomains were bound and oriented 
on RBCs modified with, respectively, anti-Fc or anti-hexahistidine antibody. When the E-
cadherin-modified RBCs were treated with anti-E-cadherin antibodies, excess cadherin was first 
removed, by centrifuging the modified RBCs, followed by resuspension in Ca2+ containing PBS. 
Then 19A11 mAb or its Fab fragments, 76D5 Fab, or DECMA-1 mAb, each at 2µg/mL, was 
incubated with the RBC cell suspension at 4 °C for 45 min. 
3.2.4 Quantification Of Cadherin Surface Expression Levels  
Flow cytometry measurements quantified the cadherin densities on cell surfaces (#/µm2) (Chien et 
al. 2008). E-cadherin expressing cells were labeled with the primary, anti-E-cadherin antibody 
DECMA-1 (Sigma-Aldrich, St. Louis, MO). DECMA-1 recognizes both the canine and human E-
cadherin used in these studies (Ozawa et al. 1990). The secondary antibody was fluorescein-
isothiocyanate (FITC)-conjugated anti-rat IgG (whole molecule, Sigma-Aldrich, St. Louis, MO). 
The antibody labeling was done in PBS containing 1w/v% BSA at pH 7.4. Calcium was omitted 
at this step, in order to prevent cell aggregation. The fluorescence intensities of labeled cells were 
measured with an LSR II flow cytometer (BD Biosciences). The calibration curve for the 
fluorescence intensity was generated with calibrated FITC-labeled standard beads (Bangs Lab, 
Fishers, IN). 
3.2.5 Treatment of Colo 205 Cells With Activating Antibodies, Staurosporine or Licl 
For studies with Staurosporine treated cells, Colo 205 cells were incubated with DMEM containing 
7nM Staurosporine (in DMSO) for 4 hours, at 37 °C in 5% CO2. These cells were then collected 
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by vigorous pipetting, and washed with PBS containing BSA and 2mM Ca2+, at least 3 times before 
use in kinetic measurements. 
Colo 205 cells were treated with either activating or neutral antibody. Additionally, we 
compared results obtained with the whole antibody versus the Fab fragment. Antibodies were 
incubated overnight with Colo 205 cells in DMEM, at a final concentration of 2µg/mL. One hour 
before the measurements, the cells were gently triturated, collected and washed twice with PBS 
containing 1 w/v% BSA and 2mM CaCl2. The same antibody used for overnight incubation was 
then re-added to the washed cells at a final concentration of 2 µg/mL, in order to insure that 
antibody remained bound to the cadherin ectodomains. These cells were gently agitated on a rocker 
at 4°C for 45 min before use.  
Colo 205 cells were incubated with 60 mM LiCl containing DMEM for 2.5 hours (37°C, 
5% CO2). After treatment, the cells were gently trypsinized with TrypLE for less than 2min, 
collected and resuspended in DMEM containing 60mM LiCl, and allowed to recover under gentle 
agitation at room temperature for 1 hr.  
Colo 205 cells were also stably transfected with wild type mouse p120 catenin (mp120ctn) 
or its variants (6 S,T A; mouse p120 WT or Neo-vector) (Petrova 2012), only the adherent Colo 
205 cells were used. p120ctn expression was verified by immunostaining, which required adherent 
cells (Fig 4A).  Thus, we did not use floating Colo 205 cells, because their p120ctn expression 
could not be verified. Nevertheless, our kinetic data did not detect any differences in the two-
dimensional affinities or the kinetic signatures measured with the floating or adherent cells (data 
not shown). The adherent Colo 205 cells were harvested with TrypLE, which does not affect 
cadherin surface expression levels, as verified by quantitative flow cytometry.  
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3.2.5 Western Blotting 
This work was done by Yuliya Petrova and Stephanie Maiden at Prof. Gumbiner’s Lab, University 
of Virginia, Charlottesville, Virginia, USA. 
Cells were collected in 1% triton X-100 with 50 mM Tris pH 7.4, 150 mM NaCl, 2 mM EDTA, 
Complete mini protease inhibitors EDTA-free (Roche Life Science), and PhosSTOP phosphatase 
inhibitor (Roche Life Science). Cells were incubated on ice for 10 min, and then vortexed 5s to 
break up cell clumps. Insoluble material was pelleted at 10,000 x g at 4°C in a tabletop centrifuge. 
The supernatant was collected and boiled for 5 min in SDS-DTT sample buffer. Samples were run 
on a 6% SDS-PAGE gel and transferred to a PVDF membrane for 3 hours at 60 V. The membrane 
was blocked for 30 min with 5% milk/PBST (phosphate buffered saline with Tween 20) and 
incubated with primary antibodies overnight at 4°C. After washing, the membrane was incubated 
with secondary antibody for 45 min at room temperature. The blot was washed 3x in PBST, and 
then imaged on a LI-COR Odyssey.  
Primary antibodies included rabbit anti-delta 1 catenin (p120catenin) monoclonal (Abcam, 
ab92514) [1:2000], mouse anti-phosphoT310 p120catenin monoclonal (kind gift from Albert 
Reynolds) [1:1000], mouse anti-E-cadherin clone 36 monoclonal (BD Biosciences) [1:5000], and 
mouse anti-α-tubulin DM1A monoclonal (Pierce, 62204) [1:2500]. Secondary antibodies used 
include IRDye goat anti-mouse 800CW and goat anti-rabbit 680RD (LI-COR) [1:10000]. 
3.2.6 Super Resolution- Structured Illumination Microscopy (SIM) 
Colo 205 cells were immunostained with an Alexa 568-labeled, neutral 76D5 Fab fragment, at a 
ratio of 2:1 (Dye: Antibody). The antibody was incubated with the cells at 37°C at a final 
concentration of 2µg/mL. After the 45 min incubation, and just before imaging, the cells were 
washed three times with phenol-red free medium, and imaged using a Zeiss ELYRA 700 
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microscope with 64X-oil immersion lens. The images were processed using the Structured 
Illumination module of the Zeiss software to obtain the super-resolved images. 
3.2.7 3D Super-Resolution Imaging (STORM) 
Setup and experiments 
The details of the STORM setup were described previously (Rust et al. 2006; Huang et al. 2008). 
Briefly, we used a microscope (Olympus IX-71 with Olympus 100X NA 1.4 SaPo oil immersion 
objective) with red (647nm, 100mW, Crystalaser, DL640-100-AL-O) and violet lasers (405nm, 
10mW, SpectraPhysics, Excelsor). The lasers were combined through dichroic mirrors and 
expanded 7.5X with a beam expander. The expanded and collimated beams were directed to a total 
internal reflection (TIR) lens, which focuses the beams at the back focal plane in the microscope, 
with an angle slightly smaller than the total internal reflectance angle. This reduced the background 
while illuminating several hundred nm along the z-axis. A dichroic mirror (Semrock 
FF408/504/581/667/762-Di01-25X36) reflected the laser lines to the objective. The emission 
signals were collected by the same objective, passing through an emission filter (Semrock FF01-
594/730-25) and two additional notch filters (Semrock NF01-568/647-25X5.0 and NF01-568U-
25), and finally imaged on a 512x512 Andor EMCCD camera (DV887ECS-BV, Andor Tech). For 
3D imaging, a cylindrical lens with a 2m focal length (SCX-50.8-1000.0-UV-SLMF-520-820, CVI 
Melles Griot) was inserted in the emission path to generate astigmatism (Huang et al. 2008). 
Because image acquisition requires tens of minutes, it was essential to correct for horizontal and 
vertical drift. The z-drift was fixed by pairing the PI piezo-objective (P-721.10) and ASI CRISP 
(Applied Scientific Instrumentation CRISP system). The horizontal drift was corrected later by 
data analysis. A home written program (C++) controlled data acquisition. The data analysis 
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algorithm was provided by Xiaowei Zhuang (Rust et al. 2006) and modified for 3D imaging 
(Huang et al. 2008). 
Cluster analysis 
E-cadherin clusters in STORM images were analyzed using the Density-Based Spatial Clustering 
of Applications with Noise approach (DBSCAN (Daszykowski et al. 2002)). Based on previous 
reports of super resolution imaging of cadherin and other proteins (Truong Quang et al. 2013a; 
Wu et al. 2015a), we fixed two parameters required for cluster allocation and analysis. First, the 
minimum distance between two points in a cluster (‘Eps’) was set at twice the theoretical resolution 
(40 nm, in this case). Second, the minimum number of points to define a cluster (‘Nps’) was set at 
20. From the resulting cluster analysis and cluster allocation, we obtained the 1) total number of 
clusters and total number of spots in clusters on individual cells; 2) diameter and number of points 
in individual clusters; 3) area of individual cells; 4) center coordinates of individual cells. Here the 
cluster “diameter” is defined as twice the average distance between the center of the cluster and 
every point in the cluster, and can be considered to be the average diameter of a cluster. 
3.3 Results 
3.3.1. Activating, But Not Neutral Antibody, Increases Cadherin Trans-Dimerization 
Affinity 
The present studies used the monoclonal antibody (mAb) 19A11, which antibody binds a 
discontinuous epitope between extracellular domains one and two (EC1 and EC2) of the E-
cadherin ectodomain (EC1-5).  It significantly enhanced Colo 205 aggregation and tight cell 
compaction, and adhesion to E-Cadherin surfaces in fluid shear assays (Petrova et al. 2012). 
Controls used the neutral antibody 76D5, which did not significantly alter Colo 205 cell 
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aggregation or MDCK cell adhesion to substrates coated with Fc-tagged ectodomains (E-Cad-Fc), 
in fluid shear assays (Petrova et al. 2012). 
Adhesion frequency measurements (Chen et al. 2008) revealed antibody-induced changes 
in the two-dimensional affinities of E-cadherin on Colo 205 cells. Fig 1C compares the binding 
probability—the number of binding events normalized by the number of cell-cell contacts—
measured between Colo 205 cells and Red Blood Cells (RBCs) modified with oriented, canine E-
Cad-Fc, with or without treatment with the activating 19A11 mAb. 
The binding probability measured with untreated Colo 205 cells rapidly increased to an 
initial plateau at P1 ~ 0.3, and then gradually increased to ~0.4 over ~20s (Fig 3.1). In sharp 
contrast, treatment with 19A11 mAb altered the kinetics qualitatively and quantitatively.  The 
binding probability rapidly increased to a higher initial plateau at P1 ~ 0.5. This was followed by 
a short 2-5 second lag, and then a further increase to a final, steady state plateau at P2 ~ 0.8 within 
20s (Fig 3.1). There was no further change, at least up to ~30s (Fig 3.1). Prior Western blots and 
determinations of cadherin surface expression levels by quantitative flow cytometry showed that 
treatment with either activating or neutral antibody did not statistically alter E-cadherin expression 
on Colo 205 cells, and was 44 ± 4 cadherins/µm2 in both cases. 
EC1-dependent trans dimerization was analysed as described before using the receptor-
ligand binding model: 
𝑃(𝑡) = 1 − 𝑒𝑥𝑝 {− [𝑚𝑅𝑚𝐿𝐴𝑐𝐾2𝐷 (1 − 𝑒𝑥𝑝(−𝑘𝑜𝑓𝑓𝑡))]}  Equation 3.1 
Here, mL and mR are the receptor and ligand surface densities (#/µm
2) on the two cells, Ac is the 
contact area (µm2), K2D is the two-dimensional binding affinity (µm
2), and koff is the off rate (s
-1). 
The ligand densities and contact areas (#/µm2) are known. The two-dimensional affinity K2D and 
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off-rate koff for trans-dimerization were then estimated from fits of Equation 1 to the data 
corresponding to the first, trans binding step—that is, the rise to P1 (Chien et al. 2008; Langer et 
al. 2012).  
To fit the data, the kinetic data was parsed between the initial binding step (rise to P1) and 
the subsequent rise to P2, using the non-linear lack-of-fit F-test (Chapter 2). In this study, trans 
binding, as modeled by Equation 3.1, described the rise to P1, but not the subsequent increase to 
P2 at times t > ~10 s. The dissociation rate and two-dimensional trans-binding affinity were then 
determined by fitting Equation 1 to the maximum number of points in each data set that did not 
fail the lack-of-fit test. The resulting weighted, nonlinear least squares (OriginLab 9.0, 
Northampton, MA) best-fit parameters are given in Table 3.1.   
Data fits showed that the 19A11 mAb treatment increased the two-dimensional affinity of 
E-cadherin on Colo 205 cells ~3 fold, relative to the untreated control.  The best-fit K2D for binding 
between E-Cad-Fc modified RBCs and Colo 205 cells and was (1.6±0.3) x 10-4 µm2, and koff was 
1.0 ± 0.2 s-1. With untreated cells, the best-fit K2D was (0.7±0.1) x 10
-4 µm2 and koff was 1.5 ± 0.4 
s-1. The apparent difference in koff for antibody-treated Colo 205 cells is insignificant at the 95% 
confidence level (N=18, p=0.2). Statistical significance is defined by p-values < 0.05.  However, 
the difference between K2D’s is statistically significant (p=0.002, N=18).  
The enhanced affinity of E-cadherin on Colo 205 cells was not due to cadherin cross-
linking by whole antibody. Measurements with the Fab fragment of 19A11 tested whether the 
enhanced affinity could be due to cadherin cross-linking by the whole 19A11 mAb (Fig 1D).  
Treatment with the 19A11 Fab gave quantitatively similar results (supplementary data in Appendix 
A): namely, the best-fit values for K2D and koff were (2.1 ± 0.3) x 10
-4 µm2 and 0.9 ± 0.2 s-1, 
respectively. The latter values are statistically similar to those measured after treatment with the 
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whole antibody (for K2D, p=0.19, N=18; for koff, p = 0.7, N=18). The best-fit parameters are 
summarized in Table 3.1.  
In controls, the Fab fragment of the neutral antibody 76D5, which did not induce Colo 205 
aggregation, had a small effect on the kinetics, relative to untreated Colo 205 cells (Fig 3.2).  The 
amplitude of the first plateau P1 increased slightly, and there was a slow, small further increase 
that slightly exceeded the binding probability of untreated Colo 205 cells at 20 s.  The fitted values 
for K2D and koff were (1.2 ± 0.2) x 10
-4 µm2 and 1.3 ± 0.3 s-1, respectively (Table 3.1). These values 
are statistically similar to the untreated Colo 205 cells (p=0.06 for K2D and p=0.7 for koff). K2D is 
statistically different from the value measured after treatment with the 19A11 Fab (p=0.02).  
Results obtained with the whole 76D5 mAb were similar to untreated Colo 205 cells (Table 3.1). 
3.3.2 Antibodies Do Not Significantly Affect The Affinity Of Recombinant E-Cadherin 
Ectodomains Or Adhesion-Competent E-Cadherin On MCF7 Cells 
It was investigated whether the activating or neutral antibodies altered the kinetics of adhesion-
competent E-cadherin extracellular domains. Bulky N-glycans on EC2 and EC3 appeared to alter 
the second binding step (P2), without affecting K2D, and the change was attributed to altered cis 
interactions (Langer et al. 2012). The neutral antibody 76D5 binds near the EC3-4 junction, and 
could similarly perturb the kinetics in ways that might not be obvious in cell aggregation studies.  
In the absence and presence of 19A11 or 76D5 Fabs, the kinetics were statistically similar to 
control measurements in the absence of antibody (Fig 3.3). Best-fit values for K2D and koff for the 
trans-dimerization of untreated E-Cad-Fc ectodomains were (2.7 ± 0.4) x 10-4 µm2 and 1.1 ± 0.3 
s-1, respectively (Table 3.1).  After treatment with activating 19A11 mAb, the fitted parameters 
were (3.0 ± 0.4) x 10-4 µm2 and 0.9 ± 0.2 s-1 for K2D and koff, respectively.  Similarly, after treatment 
with the neutral 76D5 Fab, the fitted values for K2D and koff were (2.9 ± 0.4) x 10
-4 µm2 and 1.0 ± 
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0.2 s-1. For all three, pairwise comparisons, the affinities were statistically similar (p > 0.5), as 
were the off-rates (p > 0.7).  These results confirm that the antibodies do not alter the trans binding 
parameters or the overall two-stage binding kinetics of adhesion-competent E-cadherin 
ectodomains. 
 Unlike Colo 205 cells, MCF7 cells express constitutively active E-cadherin and exhibit 
robust cell cohesion. Treatment with 19A11 antibody did not enhance the affinity of adhesion-
competent E-cadherin on MCF7 cells (Fig 3.4).  The two-dimensional E-cadherin binding affinity 
was (3.3 ± 0.4) x 10-4 µm2. Following 19A11 Fab treatment, the affinity was (4.1 ± 0.5) x 10-4 
µm2. The fitted values were not statistically different from those of untreated cells, at the 95% 
confidence level (p = 0.2).  The koff values of 1.2 ± 0.4 s
-1 and 0.9 ± 0.2 s-1 were similar for the 
treated and untreated MCF cells, respectively (p = 0.4).  By contrast, treatment with the inhibitory 
antibody DECMA-1 reduced K2D to (0.5±0.1) x 10
-4 µm2, which is slightly lower than the value 
measured with untreated Colo 205 cells (Table 3.1).  
3.3.3 Colo 205 Treatment With Staurosporine Increases The E-Cadherin Affinity 
The broad-spectrum kinase inhibitor staurosporine was shown to activate Colo 205 cell 
aggregation and p120 catenin dephosphorylation (Aono et al. 1999; Petrova et al. 2012). Here, the 
binding kinetics of staurosporine-treated Colo 205 cells (Fig 3.5) was quantitatively similar to 
19A11 Fab-treated cells: namely, K2D increased twofold to (1.5 ± 0.2) x 10
-4 µm2 (p=0.02), but the 
dissociation rate of 0.9 ± 0.2 s-1 was statistically similar to untreated cells (p=0.19) (Table 3.1). In 
controls, staurosporine had no effect on binding between E-Cad-Fc-modified RBCs, and 
confirmed that the kinase inhibitor does not affect the ectodomains directly or alter the RBCs.  
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3.3.4 Lithium Chloride (Licl) Decreases P120 Phosphorylation And Increases E-Cadherin 
Affinity On Colo 205 Cells 
Different kinases, including Glycogen Synthase Kinase 3β (GSK-3β) regulate serine/threonine 
phosphorylation of p120 catenin at various sites on the protein (Xia, 2004). Treatment with the 
GSK-3β inhibitor LiCl (Stambolic et al. 1996; Hedgepeth et al. 1997) significantly increased Colo 
205 cell aggregation and compaction, relative to control NaCl-treated cells, which remained 
rounded and dispersed (Fig 3.6). Western blots confirmed that LiCl treatment resulted in 
p120catenin dephosphorylation (Fig 3.6). Further Western blots with phospho-specific mAb to 
residue T310 of p120catenin (Xia et al. 2004; Petrova et al. 2012)—one of eight major residues 
known to be phosphorylated (Xia et al. 2003)—revealed decreased overall phosphorylation at that 
site.  
LiCl treatment of Colo 205 cells increased the E-cadherin affinity, relative to controls. As 
with staurosporine-treated cells, the initial binding probability P1 increased to an initial plateau, 
followed by a short lag, and an increase to a higher, steady state probability P2 (Fig 3.5). The fitted 
K2D was similar to that of 19A11 Fab-treated cells (2.0 ± 0.3) x 10
-4 µm2, and the dissociation rate 
was unaltered at 1.2 ± 0.3s-1 (Table 3.1), relative to untreated cells. Western blots and flow 
cytometry measurements confirmed that LiCl treatment did not significantly alter E-cadherin 
expression levels (Fig 3.5). Thus GSK-3β specifically phosphorylates p120ctn, and the p120ctn 
phosphorylation status allosterically alters the E-cadherin affinity, on Colo 205 cells. 
3.3.5 p120ctn Dephosphorylation Enhances The E-Cadherin Affinity On Colo 205 Cells  
Kinetics measurements with Colo 205 cells expressing p120ctn phosphorylation mutants 
confirmed the causal relationship between p120ctn phosphorylation and E-cadherin affinity. Fig 
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3.8 shows the binding kinetics of Colo 205 cells stably expressing either WT mouse p120ctn 
(mp120ctn) or a multi-site N-terminal phosphorylation mutant 6 S, T A, in which serine and 
threonine phosphorylation sites were mutated to alanine.  Immunofluorescence imaging confirmed 
that heterologous wild type mp120ctn localized to intercellular junctions (Fig 3.7). Negative 
controls used cells infected with the Neo vector. Colo 205 expression of the 6 S,T A mp120ctn 
mutant altered both the magnitude of the binding probability P1 and the qualitative shape of the 
time course, relative to cells expressing either WT mp120ctn or the Neo vector (Fig 4).  
Importantly, model fits of data for the initial, trans-binding step (Fig 3.8, Table 3.1) showed a more 
than threefold increase in K2D to (2.3 ± 0.3) x 10
-4 µm2 by cells expressing the 6 S,T A mutant, 
relative to K2D of (0.7 ± 0.1) x 10
-4 µm2 for cells transfected with the Neo vector. There was a 
greater than twofold increase relative to the K2D (1.1 ± 0.1) x 10
-4 µm2 determined with Colo 205 
cells expressing WT mouse p120ctn (p <0.001). 
The values of koff were statistically the same, within error, for all three conditions (p > 0.3 
in all cases). These results demonstrated that p120ctn dephosphorylation increased the E-cadherin 
affinity on Colo 205 cells, and confirms that the affinity changes are due to allosteric regulation of 
E-cadherin binding by both p120ctn-dependent, inside-out signaling and by activating antibodies. 
The nearly identical kinetic effects of all four treatments is also compelling evidence that both the 
activating antibody and p120ctn dephosphorylation alter the E-cadherin affinity by the same 
mechanism.   
3.3.6 The E-Cadherin Mutant L175D Does Not Alter The Trans Binding Affinity. 
Cadherin clustering appears to involve both the extracellular and cytoplasmic domains (Brieher et 
al. 1996; Yap et al. 1997; Hong et al. 2013; Wu et al. 2015). So it was essential to know how 
disrupting a putative cis interaction (Harrison et al. 2011) between extracellular domains affected 
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the fitted kinetic parameters, since if cis dimerization between the ectodomains enhanced the 
affinity, then its disruption would lower K2D. Kinetics measured with RBCs modified with 
ectodomains of either the WT or L175D mutant showed that in contrast to WT mE-cadherin, the 
kinetics of the mutant exhibited a single exponential rise to a limiting plateau (Chapter 4, Fig 4.2).  
The amplitudes of P1 for the mutant and WT proteins were the same, at the same cadherin 
surface density.  There was a subtle, slow increase at longer contact times, but disrupting the 
putative cis interaction between ectodomains essentially eliminated the second kinetic step. This 
result is consistent with the previous attribution of the second kinetic rise (to P2) to lateral cadherin 
interactions (Langer et al. 2012). The fitted K2D and koff values for trans-dimerization were 
statistically the same for both proteins, in agreement with measured solution binding affinities 
(Harrison et al. 2011). Thus, altering the observed lateral ectodomain interaction mediated by L175 
did not affect the trans-binding affinity of E-cadherin. 
3.3.7 Super Resolution Imaging of E-Cadherin Distributions on Colo 205 Cells 
To further test the possibility that the altered E-cadherin affinities were due to differences in 
clustering, E-cadherin clusters were imaged on unmodified Colo 205 cells, Colo 205 cells 
expressing the p120ctn 6 S,T  A mutant, and cells expressing WT p120ctn, using both Structured 
Illumination Microscopy (SIM) and Stochastic Optical Reconstruction Microscopy (STORM). 
SIM images of E-cadherin on live cells at 37 °C revealed punctate E-cadherin clusters at a 
resolution of ~130 nm on all three indicated Colo 205 cell types (Fig 3.9A i-iii). The latter images 
were obtained, after directly staining E-cadherin with the neutral 76D5 Fab labeled with Alexa 
Fluor 568. The use of labeled Fab fragments eliminated the possibility of antibody cross-linking, 
and SIM imaging of live cells eliminated fixation artifacts. Visual comparisons of the three images 
showed that there was no apparent difference in the E-cadherin clusters on individual live cells, at 
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the ~130nm resolution of SIM, despite significant differences in cell aggregation and E-cadherin 
affinity. 
The three-dimensional STORM images of fixed cells stained with whole primary and 
secondary antibodies were qualitatively similar to the SIM images (Fig 3.9B i-v). At a resolution 
of ~20nm, the expression of the p120ctn 6 S,T  A mutant did not alter the size distribution of E-
cadherin clusters, relative to unmodified cells or cells expressing WT p120ctn (Fig 3.10). E-
cadherin clusters were distributed uniformly over the cell surfaces (Fig 3.10), and their size 
distributions were similar on all three cell types, with the most probable cluster size (mode of the 
distribution) being ~100nm in all cases (Fig 3.10A and B). In control images of cells incubated 
with secondary antibody only, the number of clusters was much lower (Fig 3.10C), and the mode 
of the distribution was ~70nm (Fig 3.10A and 3.11).  
3.4 Discussion 
Kinetic studies together with biochemical treatments provide direct biophysical evidence for the 
allosteric regulation of E-cadherin binding, both by activating antibodies and by inside-out 
signaling modulated by the phosphorylation status of p120ctn. The ability of micropipette 
measurements to quantify changes in ectodomain binding due to perturbations away from the N-
terminal binding site uniquely enabled the quantitative demonstration of the allosteric regulation 
of E-cadherin.  
Receptor accumulation at cell-cell contacts (changes in mL and mR) would not account for 
the increased affinities. According to the model (Equation 3.1), this would require a ~3 fold 
increase in the overall cadherin density in the contact area. The sparse cadherin distributions on 
both cells exclude significant accumulation, within the 20sec cell-cell contact time. This 
conclusion is supported by experimental measurements of N-cadherin accumulation at smaller 
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intercellular contacts, where a ~3 fold increase in the local N-cadherin density required 15 min 
(Thoumine et al. 2005). The latter timescale is 60 times greater than that of these adhesion 
frequency measurements. Thus, cadherin accumulation through diffusion and kinetic trapping 
could not explain the affinity differences. These results support the postulate that treatments 
triggered Colo 205 aggregation by allosterically regulating the cadherin-binding affinity. The 
precise allosteric mechanism is presently not known, but could involve induced conformational 
changes, altered configurational entropy (Itoh and Sasai 2010; Motlagh et al. 2014), the activation 
of cis dimerization, or a combination of these mechanisms. 
Increased cadherin clustering could alter the measured affinity by constraining cadherins 
near ligands on the opposing cell. In adhesion frequency measurements of selectin dimers, for 
example, ligand binding by the first selectin constrained the second, and thereby enhanced binding 
to the second ligand (Zhang et al. 2013). The thermodynamics of multivalent cooperativity was 
addressed previously (Mammen et al. 1999; Kitov and Bundle 2003), and recent simulations 
demonstrated such cis-trans cooperativity within adhesion zones between model cell membranes 
(Wu et al. 2010).  
In these studies, perturbing a postulated cis-dimerization interface between extracellular 
domains did not, however, alter the trans binding affinity. The K2D’s of WT and L175D mE-
Cadherin were the same, even though L175D reduces the sizes of cadherin clusters larger than 
20nm (Wu et al. 2015a).  
Although the L175D mutant targeted extracellular domain interactions, antibody binding 
and/or p120ctn dephosphorylation could also impact transmembrane or cytoplasmic domain 
associations (Ozawa and Kemler 1998; Yap et al. 1998; Huber et al. 1999; Hong et al. 2013; 
Truong Quang et al. 2013a). There were no observed differences in clusters on treated versus 
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untreated Colo 205 cells, so that any dimerization changes would be below the resolution of 
STORM. Nevertheless, altered dimerization and/or changes in intrinsic cadherin affinities in 
response to the treatments described in this study would necessarily require allosteric regulation, 
to account for these findings. 
Consistent with an allosteric mechanism, none of the four treatments that activated Colo 
205 aggregation involved the E-cadherin trans-binding interface directly, and all generated 
quantitatively similar changes in cadherin binding kinetics.  The activating antibody 19A11 binds 
a discontinuous epitope at the EC1-2 junction (Petrova et al. 2012), and increased K2D.  Antibody 
binding altered neither the cadherin surface densities nor the two-stage kinetics of adhesion-
competent ectodomains. These results are consistent with the allosteric activation of the adhesive 
function of E-cadherin on Colo 205 cells. 
The 19A11 antibody also altered p120ctn phosphorylation, by outside-in signaling 
(Petrova et al. 2012). Staurosporine, Lithium Chloride treatment or the expression of the mp120ctn 
6S,TA mutant similarly reduced p120ctn phosphorylation (Petrova et al. 2012), and all three 
generated quantitatively similar kinetic changes as 19A11 antibody binding. The LiCl treatment 
shows that this allosteric regulation of E-cadherin activity requires a signaling pathway, which 
involves GSK-3β as a regulator of p120 catenin phosphorylation. 
All four treatments increased the E-cadherin affinities on Colo 205 cells 2-3 fold, but they 
did not alter koff. Analysis of variations (ANOVA) confirmed that the apparent differences in koff 
values obtained with 19A11-treated cells (Table 3.1) are not statistically significant, at the 95% 
confidence level.  Thus, all four treatments investigated appear to activate E-cadherin by the same 
mechanism, which enhances the E-cadherin association rate. 
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Activating antibodies did not enhance the affinity of adhesion-competent, soluble 
extracellular domains. This result indicates that the isolated fragment assumes the fully active 
conformation, which can be regulated at the cell surface, by cytoplasmic binding partners. 
Depending on the expressed kinases and their activation states, distributions of p120ctn 
phosphorylation states within a cell could generate distributions of active and inactive cell surface 
cadherins, such that activating antibodies could further increase adhesion and p120ctn 
dephosphorylation, as observed with A431 cells (Petrova et al. 2012).  A high level of constitutive 
E-cadherin activity would explain the small effect of 19A11 mAb on MCF7 cells. The possibility 
that other factors could regulate p120 phosphorylation levels—and the relative E-cadherin 
adhesive activity in different cell lines—remains to be explored. 
The activation of cell aggregation coincident with this modest 2-3 fold increase in affinity 
is not surprising because aggregate size is not thermodynamically controlled and does not scale 
with either affinity or adhesion energy. The onset of aggregation indicates that the intercellular 
adhesion energy exceeds the threshold ambient (background) thermal energy (Hunter 1989). 
Importantly, the kinetic measurements quantified binding affinities—not adhesion energies. Our 
results leave open the possibility that factors, in addition to cadherin affinity modulation, could 
augment Colo 205 cohesion, such as signaling by activated E-cadherin ligation, receptor 
accumulation or cytoskeletal remodeling. 
The neutral Fab 76D5, which did not induce Colo 205 aggregation (Petrova et al. 2012), 
modestly altered the dissociation rate koff. However, the antibodies were classified based on 
qualitative cell aggregation or shear flow assays (Petrova 2012), and the small kinetic change 
induced by 76D5 mAb may not cause detectable differences in cell adhesion or aggregation.  
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Evidence for the allosteric regulation of cadherin adhesion is currently based on functional 
data. Although structures might reveal the basis of E-cadherin regulation, increasing experimental 
evidence exposed the limitations of classical, structure-based models of allostery (Kern and 
Zuiderweg 2003; Itoh and Sasai 2010; Law et al. 2014; Motlagh et al. 2014).  It is often unclear 
how different conformations are functionally interconnected. In the context of ‘dynamic allostery’ 
(Cooper and Dryden 1984; Motlagh et al. 2014), altered conformational dynamics and associated 
entropic changes could also perturb binding, without changing the average protein structure. 
Indeed structural fluctuations and their suppression appear to influence cadherin interactions at 
cell surfaces (Sotomayor and Schulten 2008; Wu et al. 2010; Wu et al. 2011). Thus, structures can 
support—but not prove—allostery. Within this current view, functional data are necessary and 
sufficient evidence for allosteric regulation.   
In summary, adhesion frequency measurements enabled the unique, quantitative 
demonstration of allosteric regulation of homophilic, E-cadherin binding by p120ctn 
phosphorylation status. Fig 3.12 illustrates a postulated mechanism, based on the available data. 
Here, the initially low E-cadherin K2D results in low binding probabilities (Fig 3.12A). Activating 
antibody allosterically alters the cytoplasmic domain, resulting in p120ctn de-phosphorylation by 
outside-in signaling (Petrova 2012) (Fig 3.12B). Inside-out signaling then increases the cadherin 
affinity, which increases the measured cell-cell binding probability (Fig 3.12C).  The antibodies 
could also allosterically influence the binding site directly. The activating antibody had no 
detectable effect on isolated cadherin ectodomains, as expected, if the fragments adopt a 
constitutively activate conformation. 
 
 60 
 
Allosteric regulation is an efficient mechanism for propagating signals through large 
cadherin structures.  Intriguingly, the large number of cadherin superfamily members whose 
cytoplasmic domains and binding partners are kinase targets suggests that allosteric regulation 
may be a more common mechanism than previously thought, with important consequences for 
morphogenesis and the controlled regulation of tissue functions.  
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3.5 Figures and Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  Activating antibody 19A11 enhances the binding kinetics of E-cadherin on Colo 
205 cells. Binding probability versus contact time between RBCs displaying oriented canine E-
Cad-Fc (23 or 28 cadherins/m2) and Colo 205 cells (40 cadherins/m2) with (black squares) or 
without (grey squares) treatment with whole 19A11 monoclonal antibody. The initial plateau, P1, 
lag, and steady state plateau P2 are shown for the kinetic time course measured with 19A11 
antibody-treated Colo 205 cells. Controls (white squares) were done with RBCs without 
immobilized E-Cad-Fc.  The solid and dashed lines are the non-linear least squares fits of data for 
the first kinetic step to Eq. 3.1. The best-fit parameters are given in the text and summarized in 
Table 3.1.   
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Figure 3.2. Neutral antibody does not affect Colo 205 E-cadherin Kinetics. Binding probability 
versus the contact time between RBCs modified with oriented E-Cad-Fc (12 cadherins/m2) and 
Colo 205 cells (40 cadherins/m2) treated with Fab fragments of either the activating 19A11 (black 
squares) or neutral 76D5 antibody (gray squares). Controls were done with RBCs without bound 
cadherin extracellular domains (white squares). The solid and dashed lines are the non-linear least 
squares fits of data for the first kinetic step to Eq. 1. The best-fit parameters are given in the text 
and summarized in Table 3.1.  
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Figure 3.3. Activating 19A11 antibody does not alter homophilic binding kinetics of 
adhesion-competent E-cadherin. Binding probability versus contact time between RBCs 
modified with adhesion-competent E-Cad-Fc (19 cadherins/m2) treated with Fab fragments of 
either 19A11 (black squares) or neutral 76D5 (grey squares). Controls were with RBCs without 
immobilized E-Cad-Fc (white squares) or with RBCs with immobilized E-Cad-Fc without 
antibody (white circle). The solid, dashed, and dotted lines are nonlinear least squares fits of data 
corresponding to the first kinetic step to Eq. 3.1, with best fit parameters given in the text and 
summarized in Table 3.1. 
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Figure 3.4. Activating 19A11 antibody does not alter homophilic binding kinetics of 
adhesion-competent E-cadherin in MCF 7 cells. Binding probability versus the contact time 
between RBCs modified with canine E-Cad-Fc (35 cadherins/m2) and adhesion competent E-
cadherin on MCF7 cells (10 cadherins/m2) with (black squares) or without (gray squares) 19A11 
Fab. White squares indicate measurements with inhibitory, anti-E-cadherin DECMA-1 antibody 
(white circles). The lines indicate nonlinear least squares fits of the initial trans-binding step to Eq. 
3.1, with 19A11 Fab (solid line), without antibody (light dashed line), or with DECMA-1 
inhibitory antibody (dark broken line). The best-fit parameters are given in the text and 
summarized in Table 3.1. 
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Figure 3.5. Lithium chloride inhibits p120 catenin phosphorylation (A) Colo 205 cells after a 
2hr incubation with LiCl, relative to NaCl control. (B) Western blot using the phosphospecific 
anti-p120 catenin antibody targeting pT310 of after Colo 205 treatment with LiCl, relative to NaCl 
control. Tubulin was used as a loading control. E-cadherin surface expression was unaffected. 
  
A 
B 
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Figure 3.6. Inhibiting p120 phosphorylation increases E-cadherin affinity.  Binding 
probability versus contact time between RBCs modified with immobilized, oriented E-Cad-Fc (23 
cadherins/m2) and Colo 205 cells (40 cadherins/m2) treated with Staurosporine (black squares) 
or LiCl (grey diamonds), relative to NaCl-treated control cells (white squares). Controls (white 
circles) used RBCs without immobilized E-Cad-Fc. The lines through the data are weighted, 
nonlinear least squares fits to Eq. 3.1, with best-fit parameters given in the text and summarized in 
Table 3.1. 
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Figure 3.7 Colo 205 transfected with p120 catenin mutants have normally localized E-
cadherin. Immunostained E-cadherin and p120 catenin in adherent Colo 205 mouse p120 catenin 
transfectants. Colo 205 cells were transfected with the neomycin vector (Neo Vector), with a vector 
encoding wild type mouse p120ctn (WT mp120ctn), or with a vector encoding the mouse p120ctn 
phosphorylation mutant (6S, TA mp120ctn).  The top row shows cells stained with anti-human 
E-cadherin antibody (green). The bottom row shows cells immunostained with anti-mouse 
p120ctn. 
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Figure 3.8. p120ctn phosphorylation status regulates E-cadherin binding. Binding probability 
versus the contact time between RBCs modified with immobilized, oriented E-Cad-Fc (12 or 25 
cadherins/m2) and Colo 205 cells expressing WT mp120ctn (grey squares, 40 cadherins/m2), 
the mp120ctn 6S, TA phosphomutant (black squares, 51 cadherins/m2), or infected with the 
Neo vector (white squares, 44 cadherins/m2).  Controls (white circles) used RBCs without 
immobilized E-Cad-Fc and untreated Colo 205 cells. The lines through the data are weighted, 
nonlinear least squares fits of kinetic data to Eq. 3.1, with best-fit parameters given in the text and 
summarized in Table 3.1. 
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Figure 3.9. Super Resolution Images of Cadherin Clusters on Colo 205 Cells. (A) Structured 
Illumination Microscopy of Colo 205 cells. SR-SIM of live Colo 205 derivatives was performed 
at 37 ° C, after directly labeling live cells with the Alexa-568-labeled Fab fragment of 76D5, which 
binds the human E-cadherin extracellular domain: (i) untransfected Colo 205 (ii) Colo 205 
expressing mp120 WT (iii) Colo 205 expressing mp120 6 S, T A. (B) Stochastic Optical 
Reconstruction Microscopy (STORM) of E-cadherin clusters on Colo 205 cells. STORM imaging 
of E-cadherin on Colo 205 cells immunostained with (i) control anti-rat Alexa 647 secondary 
antibody; and (ii), (iii), (iv) with anti-E-cadherin primary DECMA-1 and secondary anti-rat 
antibodies. E-cadherin clusters are concentrated at the cell periphery. Control data show negligible 
clusters. (v) An expanded section of the cell surface in (iv).  
 
A 
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Figure 3.10. Analysis of E-Cadherin Clusters on Colo 205 Cells. Comparison of E-cadherin 
clusters on WT Colo 205 cells, Colo 205 expressing WT mp120, and Colo 205 cells transfected 
with mp120 6S,T  A  (A) Cluster diameter, (B) number of points per cluster, (C) total number 
of clusters per cell, and (D) percent clustering [(points per cluster x number of clusters)/ total 
points]. Apart from the control, there are no significant differences between the features of clusters 
on the three Colo 205 cell lines. 
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Figure 3.11. Cumulative analysis of E-cadherin clusters on Colo 205 Cells. Histograms of the 
number of E-cadherin clusters on Colo 205 cells versus the cluster diameter (nm). N > 6 cells were 
analyzed each for untransfected Colo 205 cells and Colo 205 cells transfected with WT mp120ctn 
or mp120ctn 6S,TA. The gray curves are Gaussian fits of the cluster distributions, obtained with 
each cell line. 
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Figure 3.12.  Proposed model for the allosteric activation of E-cadherin. (A) The low E-
cadherin affinity on untreated Colo 205 results in little bond formation and low cell-cell binding 
probabilities. (B) Activating antibody treatment or the expression of the phosphorylation mutant 
mp120ctn 6S, TA decreases p120ctn phosphorylation, and activates E-cadherin-mediated cell 
aggregation. (C) The substantially higher E-cadherin following activating antibody treatment or 
expression of the p120ctn phosphomutant 6S, TA increases the frequency of homophilic E-
cadherin bonds and the measured cell-cell binding probabilities. 
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Table 3.1. Summary of best-fit values of K2D and koff from kinetic data. The Left and Right sides refer 
to the two micropipettes holding opposing cells. The right side is the Red Blood Cell labeled with the 
desired E-cadherin ectodomain. The cadherin densities were quantified by flow cytometry. 
 
Left Side micropipette Right side micropipette K2D  
(x10-4 µm2) 
koff (s
-1) 
Cell Line Cadherin  
per µm2 
RBC surface Cadherin  
per µm2 
Colo 205 
(non adherent) 
40 E-cad-Fc 23 0.7 ± 0.1 1.5 ± 0.4 
Colo 205 
(adherent) 
44 E-cad-Fc 25 0.7 ± 0.1 1.0 ± 0.3 
Colo 205 
+ 19A11 mAb 
40 E-cad-Fc 28 1.6 ± 0.3 1.0 ± 0.2 
Colo 205 
+ 76D5 mAb 
40 E-cad-Fc 28 0.8 ± 0.1 0.9 ± 0.3 
Colo 205 
+ 19A11 Fab 
40 E-cad-Fc 12 2.1 ± 0.3 0.9 ± 0.2 
Colo 205  
+ 76D5 Fab 
40 E-cad-Fc 12 1.2 ± 0.2 1.3 ± 0.3 
Colo 205  
+ Staurosporine 
40 E-cad-Fc 23 1.5 ± 0.2 0.9 ± 0.2 
Colo 205 +Lithium 
Chloride 
40 E-cad-Fc 14 2.0 ± 0.3 1.2 ± 0.3 
Colo 205 
mp120ctn 6 
S,TA  
51 E-cad-Fc 12 2.3 ± 0.3 0.9 ± 0.2 
Colo 205 
mp120ctn WT 
40 E-cad-Fc 25 1.1 ± 0.2 1.0 ± 0.2 
Colo 205 
Neo vector 
44 E-cad-Fc 25 0.7 ± 0.1 1.2 ± 0.3 
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Table 3.1 (cont.)  
 
 
  
E-cadherin-Fc 
 
19 E-cad-Fc 19 2.7 ± 0.4 1.1 ± 0.3 
E-cadherin-Fc 
+ 19A11 Fab 
19 E-cad-Fc  
+19A11 Fab 
19 3.0 ± 0.4 1.0 ± 0.2 
E-cadherin-Fc 
+ 76D5 Fab 
19 E-cad-Fc  
+76D5 Fab 
19 2.9 ± 0.4 1.0 ± 0.2 
E-cadherin-Fc 
+DECMA-1  
29 E-cad-Fc 
+DECMA-1  
29 0.5 ± 0.1 0.8 ± 0.2 
WT Mouse  
E-cad-His  
21 WT mouse  
E-cad-His   
21 3.3 ± 0.5 1.0 ± 0.2 
 
Mouse E-cad-His 
L175D 
22 L175D mouse 
E-cad-His  
22 3.0 ± 0.4 0.9 ± 0.1 
MCF 7 10 E-cad-Fc 35 3.3 ± 0.4 0.9 ± 0.3 
MCF 7  
+ 19A11 Fab 
10 E-cad-Fc 35 4.1±0.5 1.2±0.4 
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CHAPTER 4 
Kinetic measurements reveal complex cadherin 
interactions at confined cell-cell junctions 
This chapter has been reformatted from its published version in Scientific Reports (Nature). 
[Reference: Shashikanth N, Kisting MA, Leckband DE. 2016. Kinetic Measurements Reveal 
Enhanced Protein-Protein Interactions at Intercellular Junctions. Scientific reports 6: 23623] 
 
4.1 Introduction 
Adhesion proteins function in confined regions between cell membranes and the extracellular 
matrix or adjacent cells.  Studies of the binding mechanisms of adhesion proteins, like cadherins, 
are typically based on investigations of binding between soluble, recombinant fragments of 
membrane proteins. Apart from possible functional perturbations stemming from the use of 
recombinant fragments, theoretical models and experimental findings suggest that affinities 
measured in solution differ quantitatively from those determined in quasi two-dimensional gaps at 
adhesive contacts (Dustin et al. 1996; Chesla et al. 1998; Dustin et al. 2001; Williams et al. 2001; 
Zhang et al. 2005; Wu et al. 2008; Huang et al. 2010; Wu et al. 2010; Wu et al. 2011; Hu et al. 
2013).   
Cadherins are exemplary proteins for testing whether confinement alters adhesion protein 
interactions. They can assemble into dense plaques at intercellular adhesions that are characterized 
by high cadherin densities associated with a dense actin belt (Yonemura et al. 1995; Hartsock and 
Nelson 2008). Intermembrane gaps at cadherin-mediated adhesion zones are typically ~35nm 
(Harrison et al. 2011).  Structures and electron density images of adhesion zones suggest that 
cadherins perhaps undergo lateral interactions in addition to their initial trans-interactions 
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mediated by tryptophan (W2)- EC1 docking between opposing cadherins. Although there was 
some biophysical evidence suggesting that lateral ectodomain dimerization enhanced activity, 
diverse biophysical approaches did not detect lateral bonds between soluble, recombinant 
ectodomains (Brieher et al. 1996; Koch et al. 1997; Koch et al. 1999; Ahrens et al. 2002; Zhang et 
al. 2009). In addition to the initial ‘strand-swapped dimer’ (Fig 4.1b), structural analyses identified 
two, additional possible binding interfaces: one trans bond between opposed proteins, deemed the 
‘X-dimer’ (Fig 4.1a), and a potential cis (lateral) binding interface (Fig 4.1c) (Ciatto et al. 2010; 
Harrison et al. 2010). Although X-dimers (Fig 4.1a) form in solution, the lateral interaction 
observed in crystals was not detected in solution, even at high protein concentrations (Tomschy et 
al. 1996; Haussinger et al. 2002; Harrison et al. 2010). However, mutations at the putative cis 
(lateral) binding interface disrupted cadherin organization at artificial junctions between giant 
vesicles (Harrison et al. 2011) and perturbed cadherin distributions at cell-cell junctions (Strale et 
al. 2015).    
Molecular Dynamics and Monte Carlo simulations suggested a possible physical basis for 
apparent discrepancies between solution binding data, crystal structures, and force probe 
measurements. The simulations predicted that binding between flexible cadherin ectodomains on 
opposing cells pins the proteins, and reduces their configurational entropy. This could in turn 
reduce the entropic repulsion between proteins on the same membrane, enabling the formation of 
weak lateral (cis) protein-protein bonds. Confining adhering cadherins within intermembrane 
adhesion zones could thus expose lateral interactions that are otherwise not observed (Wu et al. 
2010; Wu et al. 2011). 
The simulation results further suggested that cadherins on the same membrane associate 
laterally (cis bonds) in adhesion zones, but that cis bond formation requires the initial pinning of 
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opposing, adhering cadherin ectodomains. However, cadherins form clusters of > 5 proteins on 
free (unconfined) membranes (Wu et al. 2015), and their connections to actin 
assembly/disassembly dynamics, endocytosis, and cadherin binding interactions reportedly 
regulate the assembly of much larger cadherin clusters at intercellular contacts (Cavey et al. 2008; 
Hong et al. 2013; Truong Quang et al. 2013; Biswas et al. 2015). The quantitative manifestations 
of the impact of confinement on cadherin interactions are currently unclear. A further open 
question is whether predicted confinement-enhanced cadherin interactions alter physiologically 
relevant properties of intercellular junctions. 
The results in this chapter describe E-cadherin mediated, intercellular binding kinetics, and 
provide quantitative evidence for confinement-enabled cadherin interactions within intercellular 
junctions. Measurements of the adhesion frequency between cell pairs revealed a unique kinetic 
signature that reflects initial trans (adhesive) cadherin bond formation, which is then followed by 
a second kinetic process attributable to the onset of cis (lateral) interactions within tens of seconds 
of initial cell-cell contact. Kinetic studies and super resolution imaging of cadherin mutants that 
were postulated to disrupt lateral interactions, support this interpretation.  Measurements with 
recombinant cadherin ectodomains and with full-length transmembrane cadherins further 
confirmed that the kinetic signatures were independent of cytoskeletal interactions. These results 
thus provide biophysical evidence that quasi two-dimensional confinement quantitatively alters 
adhesion protein (cadherin) interactions, which affect the assembly and function of intercellular 
junctions. Comparisons of kinetics with cell and tissue functions reveal the potential physiological 
significance of these findings.  
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4.2 Materials and Methods 
4.2.1 Plasmids, cell lines and proteins 
CEP 4.1 plasmids encoding the hexahistidine-tagged, wild type mouse E-cadherin ectodomain (E-
Cad-His6) and mutants V81D and L175D were from Dr. Lawrence Shapiro (Columbia University, 
NY) (Harrison et al. 2011). The plasmid encoding the full-length Human E-cadherin-GFP (Hu-E-
Cad-GFP) was from Dr. Jennifer Stow (Addgene plasmid # 28009) (Miranda et al. 2001). V81D 
and V175D mutations to the Hu-E-Cad-GFP construct were introduced, as mentioned below. 
 Site-directed Mutagenesis for generating E-cadherin cis interface mutants 
The pcDNA3.1 vector with the gene for human E-cadherin with GFP (Addgene) was obtained and 
mutated using site-directed mutagenesis. The forward and reverse primers for site-directed 
mutagenesis were designed using PrimerX to be 25 to 45 nucleotides in length, have a GC content 
between 40% and 60%, end in at least one G or C, and have a melting temperature above 60° C.  
Primers differing from the wild type gene sequence were prepared for the two cis-interface 
mutants, V81D (forward primer 5’- CTCTCACGCTGATTCATCCAACGG -3’, reverse primer 
5’-CCGTTGGATGAATCAGCGTGAGAG-3’) and V175D (forward primer 5’-
GAGTCAGTGTGGATACCACTGGG-3’, reverse primer 5’-
GTCCAGCCCAGTGGTATCCACACTGAT-3’). The primers were solubilized in sterile water to 
a working stock concentration of 10 pM. The wild type E-Cadherin served as the template and was 
diluted to a working stock concentration of 10 ng/μL. In accordance with the site directed 
mutagenesis protocol, the PCR reaction mixture contained 50 ng of template and 150 ng of each 
primer at a 3:1 mass ratio. The reaction mixture also contained NEB Phusion High-Fidelity 
polymerase, 1X NEB high fidelity polymerase buffer, dNTPs, and 5 v/v% DMSO. Mutagenesis 
 79 
 
was achieved using the following thermocycler program: initial denaturation for 3:00 min at 98° 
C, then 18 cycles of denaturation for 2:00min at 98° C, annealing for 0:50 min at a temperature 
specific to each primer pair, and elongation for 9:00 min at 72° C. The final elongation ran for 
15:00 min at 72° C. 
The PCR product following the mutagenesis was purified with the Qiaquick PCR 
Purification Kit (Qiagen) and the concentration and purity was checked using a Nanodrop (Thermo 
Scientific). A restriction digestion using enzyme Dpn1 (NEB) was performed to destroy 
methylated, un-mutated, template plasmid. Following digestion, a portion of the plasmid was 
verified to be the correct size, 8.1 kb, by agarose gel electrophoresis on a 1% agarose gel. 
Following another purification to remove the Dpn1, using the same PCR purification kit, the 
plasmid containing E-Cadherin was transformed into competent DH5α bacteria. About 3 ng of 
DNA were introduced to the cells and were allowed to sit on ice for 30 minutes. Next, a 90 second 
heat shock at 42° C was performed followed by another 5 minutes on ice. The cells were then 
placed on a shaker for one hour at 37° C in 1 mL of LB medium to enable their recovery. The 
DH5α cells were plated on an ampicillin containing LB plate and incubated overnight at 37° C.  
For every mutation, six transformed colonies were chosen from the ampicillin plate and cultured 
overnight in 3 mL of LB with ampicillin at 0.1 mg/mL. A Qiaprep Miniprep Kit (Qiagen) was 
used to isolate the plasmid from genomic DNA and cellular debris. The six samples were submitted 
to the University of Illinois Core Sequencing Facility, along with custom sequencing primers 
designed to anneal to the sequence upstream of the desired mutation. The results were obtained 
and compared to the original sequence. One clone confirmed to carry the desired mutation was 
chosen to be transformed into DH5α bacteria and cultured in ampicillin containing LB to prepare 
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a plasmid stock, followed by midiprep DNA isolation (Promega) using the manufacture’s protocol, 
to isolate large amounts of the plasmid. These plasmid stocks were stored at -20° C. 
Creation of A431D stable cell lines 
The human Embryonic Kidney (HEK) 293T cell line was from the American Type Culture 
Collection (Manassas, VA). A431D Epidermoid Carcinoma cells, which do not express 
endogenous E-cadherin (Lewis et al. 1997) were from Dr. Keith Johnson (University of Nebraska, 
Lincoln). Cells were cultured in Dulbecco’s Minimum Eagle Medium (DMEM) containing 10% 
fetal bovine serum (FBS) (Life Technologies, Carlsbad, CA) in a 5% CO2 atmosphere at 37°C. 
Cell lines that stably expressed the soluble proteins were generated, by transfecting Human 
Embryonic Kidney 293T cells with the constructs indicated above, using Lipofectamine 2000 
(Invitrogen, Grand Island, NY) according to the manufacturer’s instructions.  
HEK 293T lines stably expressing hexahistidine-tagged, soluble ectodomains were 
selected with 200 µg/mL Hygromycin B (Invitrogen). Western blots of the collected, concentrated 
culture media assessed protein expression by individual colonies. The colonies that expressed the 
highest levels of soluble protein were chosen for further culture and use for soluble protein 
production. Secreted, hexahistidine-tagged proteins were purified from filtered culture medium, 
by Ni/NTA affinity chromatography, and subsequent ion-exchange chromatography.  
Stable cell lines that expressed full-length Hu-E-Cad-GFP or its mutants were generated 
by transfecting A431D cells, using Lipofectamine 2000, and clones were selected using geneticin 
sulfate (400 µg/mL). Fluorescence Activated Cell Sorting (FACS) was used to select cell 
populations with similar median GFP intensity, indicating similar cadherin surface expression 
(cadherins/µm2).  
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4.2.2 Red Blood Cell (RBC) isolation, modification, and E-cadherin labeling.  
Protocols were followed as detailed in Chapter 2. 
4.2.3 Quantification of cadherin surface expression  
Flow cytometry measurements quantified the density of surface-expressed cadherin 
(cadherins/µm2). E-cadherin expressing cells were labeled with the primary, anti-E-cadherin 
antibody DECMA-1 (Sigma-Aldrich, St. Louis, MO), which binds the fifth extracellular repeat 
domain (EC5) of murine and human E-cadherin (Ozawa et al. 1990). The secondary antibody was 
CFL-647 - conjugated anti-rat IgG (whole antibody, Santa Cruz Biotech, TX). The antibody 
labeling was done in 1X PBS containing 1w/v% BSA at pH 7.4. A description of the flow 
cytometry analysis is provided in detail in Chapter 2. 
4.2.4 Micropipette Measurements of Cell Binding Kinetics  
Micropipette adhesion frequency assay was carried out between either A431D cells expressing 
Hu-E-Cad-GFP or its mutants and corresponding mutated ectodomains on RBCs, or simply using 
just purified ectodomain modified RBCs in both pipettes, in order to selectively study the influence 
of the absence of cadherin cytoplasmic domain. The detailed protocol is described in Chapter 2 of 
this thesis. 
4.2.5 Scratch Wound Healing Assay 
Wound healing assays were performed with A431D cells that stably expressed WT Hu-E-Cad-
GFP or its V81D, V175D, or V81D/V175D mutants. Cells were grown to confluence in glass 
bottom dishes (Cell E & G, Houston, TX). After wounding the monolayer with a 200 µL pipet tip, 
the cells were washed gently with medium three times, and imaged at the same spot at 
approximately 2 hour time intervals, using a 20X objective (phase contrast) on a Zeiss Axiovert 
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200 microscope. In the intervals between the measurements, the cells were maintained at 37 °C in 
5% CO2. These images were analyzed using the Zeiss Axiovision (Version 4.2) software. For each 
image, outlines of the gaps were drawn on both the leading edges over a length of 150 µm, and the 
remaining gap area was calculated (N = 25). The percentage of the remaining gap area, relative to 
the initial wound area, was plotted as a function of incubation time for the different cell lines. A 
Student’s t-test was performed to test for significance, using the standard errors for all cell lines at 
the 4 hour time point.  
4.2.6 Paracellular Permeability  
A431D cells were grown to confluence on Corning Transwell inserts for 5-7 days to ensure that 
cells covered the entire surface of the insert. On the day of the assay, the cells were washed with 
Hank’s Balanced Buffer Solution (HBSS), and the upper chamber was filled with HBSS that 
contained a defined concentration of BSA conjugated to Evans blue (8:1 ratio, referred to as 
‘stock’). After 2.5 hours, samples from the lower chamber were collected in triplicate for each 
experiment. The dye fluorescence was measured using a SpectraMax® M2 Multi-detection 
spectrophotometer, with excitation at 540 nm and emission at 680 nm. A calibration curve was 
plotted for each experiment, using defined concentrations of Evans Blue-BSA. The percentage of 
dye leaked into the lower chamber was determined from the sample mean fluorescence intensities, 
calculated from the slope of the calibration curve. 
4.2.7 Super Resolution- Structured Illumination Microscopy (SR-SIM) 
A431D cells expressing full length, GFP-tagged E-cadherin or its mutants were cultured in 35mm 
glass bottom dishes. On the day of the experiment, the cells were nearly 80% confluent. These 
cells were washed 3 times with DMEM (without phenol red) and immediately imaged for GFP by 
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excitation with a 488nm laser on a Zeiss ELYRA 700 microscope with a 64X-oil immersion lens. 
The images were processed using the Structured Illumination module of the Zeiss (Zen 2011) 
software to obtain the super-resolved images of E-Cad-GFP. The spatial resolution of the 
instrument is 150 nm. 
4.3 Results 
4.3.1 Distinct Kinetic Signature Requires Putative Lateral (Cis) Cadherin Interactions 
Cadherin-mediated, intercellular adhesion frequency measurements, using the dual micropipette 
set-up, were first carried out with RBCs ectopically modified with mouse E-Cad-His6, in both 
micropipettes. As shown in Fig 4.2, the binding probability initially rose to an initial steady-state 
plateau P1 ~ 0.5, followed by a brief lag, and then a second increase in binding probability to a 
plateau at P2 ~ 0.8. This distinct two-stage or ‘biphasic’ kinetic signature is a general feature of 
all type I classical cadherins studied so far (Chien et al. 2008; Langer et al. 2012; Tabdili et al. 
2012). Prior studies with binding site mutants and domain deletion mutants demonstrated that the 
initial increase to the first plateau, P1 is due to trans (adhesive) binding (Chien et al. 2008; Tabdili 
et al. 2012).  
In measurements with the V81D and L175D mutants, the initial rise in binding probability 
was similar to that of WT mouse E-Cad-His6, at comparable surface densities.  However, the 
further increase in binding probability (second stage) was much slower (Fig 4.2). With the V81D 
mutant, at 40s, the second rise reached a probability of P2 ~0.8, similar to that of WT E-Cad-His6. 
With L175D, the second rise was even slower, and the binding probability at 40 s (~0.7) was 
slightly lower than that of WT E-cadherin (p = 0.05, Nexp = 3). The final steady state plateau could 
not be determined for L175D, on account of the instrument drift over much longer contact times. 
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The double mutant V81D/L175D completely abolished the second increase in binding probability 
(to P2). Controls with RBCs modified only with anti-hexahistidine antibody confirmed the 
cadherin-specificity of the measured adhesion frequency time courses (Fig 4.2). 
In order to quantify the trans (adhesive) binding parameters, the kinetic data was parsed 
between the initial rise to P1, and the subsequent rise to P2, using the non-linear lack-of-fit F-test 
as detailed in Chapter 2. In this study, trans binding, as modeled by Eq. 1 (Chapter 2), described 
the rise to P1, but not the subsequent increase to P2 at t > ~10 s. The dissociation rate and two-
dimensional affinity of trans (adhesive bonds) were determined from fits of Eq. 1 to the maximum 
number of points in each data set that did not fail the lack-of-fit test. In the case of the V81D/L175D 
mutant, all the data points were included in the fits. The lines in Fig 4.2 and 4.3 are the weighted, 
nonlinear least squares fits (OriginLab 9.0, Northampton, MA) of data corresponding to the initial 
rise to P1, with the best-fit parameters summarized in Table 4.1. 
The data fits revealed that the 2D-binding affinity (K2D) and off-rate (koff) for trans binding 
(Fig 4.2) by WT mouse E-Cadherin and both mutants (see Table 4.1) were statistically similar. 
The p-values at the 95% confidence level in two-tailed statistical analyses were > 0.1, regardless 
of the pairwise comparisons. Although the cis interface mutations altered the kinetic profiles 
qualitatively, they did not affect the trans binding parameters, in agreement with solution binding 
measurements of recombinant ectodomains with these same mutations (Harrison et al. 2011).  
4.3.2 Two-Stage Kinetic Signatures Are Independent of the Cadherin Cytoplasmic Domain 
To assess whether the kinetic behavior measured with cadherin ectodomains reflected the behavior 
of membrane-bound cadherins, adhesion frequency measurements were performed with A431D 
cells that stably expressed human E-cadherin-GFP or its cis (lateral) interface mutants. Fig 4.3 
shows the adhesion frequency time courses measured between A431D cells expressing either WT 
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Hu-E-Cad-GFP or the double mutant V81D/V175D Hu-E-Cad-GFP and RBCs ectopically labeled 
with the same ectodomain—that is, with WT E-Cad or the V81D/V175D mutant. Based on 
quantitative flow cytometry measurements, the surface expression of Hu-E-Cad-GFP (WT or 
V81D/L175D) on A431D cells were similar (Table 4.1). The kinetics were also qualitatively and 
quantitatively similar to those measured with the ectodomains alone (compare with Fig 4.2). 
Binding between cells expressing WT Hu-E-Cad-GFP and RBCs modified with WT E-Cad-His6 
exhibited a two-stage kinetic time course, in which the second rise to P2 occurred after 7 s. In 
measurements between cells expressing V81D/V175D Hu-E-Cad-GFP and RBCs modified with 
V81D/V175D E-Cad-His6, the second increase in binding probability was abolished, but the 
determined trans (adhesive) binding affinity and off-rate were statistically similar to WT E-
cadherin (Table 4.1, p > 0.1).   Thus, within the initial 40s of cell-cell contact, the quantitative and 
qualitative features of the E-cadherin mediated binding kinetics were independent of the 
cytoplasmic domain. 
4.3.3 Lateral (Cis)-Interface Mutants Alter Cadherin Organization at Junctions but Not On 
Free Membranes 
Super Resolution Structured Illumination Microscopy (SR-SIM) imaging then determined whether 
the putative cis binding-interface between ectodomains altered the organization of E-cadherin both 
at A431D intercellular junctions and at the free edges of cells outside contact regions. Different 
from super resolution Stochastic Optical Reconstruction Microscopy (STORM) imaging of E-
cadherin nanoclusters (Wu et al. 2015), SR-SIM imaged cadherin clusters on live cells without 
fixation, antibody labeling or use of oxygen-scavenging buffers to enhance the image stability. 
The SR SIM resolution (~150nm) is less than STORM but twice that of confocal microscopy, and 
sufficient to characterize cadherin clusters with diameters > 20nm (Shashikanth et al. 2015).  
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SR SIM images revealed distinct punctate cadherin clusters at junctions between A431D 
cells stably expressing WT E-Cad-GFP. The adhesion plaques observed between live (unfixed) 
A431D cells expressing WT E-Cad-GFP (Fig 4.4) were similar to the large, dense cadherin plaques 
at junctions observed in 3D-STORM images (Wu et al. 2015). However, such defined, puncta were 
not visible with any of the cis-interface mutants, and clusters were smaller and more diffuse at 
cell-cell junctions (Fig 4.4). Outside of cell-cell contacts, there was no apparent cadherin 
organization, and the E-Cad-GFP was diffuse, even on cells expressing WT E-Cad-GFP (Fig 4.4). 
Thus, the cis interface mutants altered the organization of cadherins at cell-cell junctions, but did 
not affect cadherin organization outside of adhesion zones. 
4.3.4 Perturbed Cadherin Interactions Alter Intercellular Junction Integrity 
The potential physiological impact of the cis interface mutants with the altered binding kinetics 
was compared using two, cell-based assays: scratch wound healing (Fig 4.5) and paracellular 
permeability (Fig 4.6). In scratch wound healing assays, A431D cells stably expressing the cis 
interface mutants closed wounds much faster than cells expressing WT E-Cad-GFP (Fig 4.5). 
Within nine hours, the cells expressing WT E-cadherin closed only ~70% of the wound, whereas 
cells expressing the cis interface mutants completely closed wounds of similar size, within the 
same time frame (Fig 4.5).  At 4hrs, for example, the remaining wound area was greater for cells 
expressing WT E-Cad-GFP relative to the V81D mutant (p=0.005, N=6), but all mutants were 
similar (p > 0.3 for all pairwise comparisons; N=6 in each case).  
The paracellular permeabilities of confluent A431D cells expressing E-cadherin-GFP or 
the cis interface mutants revealed that the expression of WT E-Cad-GFP reduced epithelial barrier 
permeability significantly, relative to untransfected A431D cell monolayers (Fig 4.6). This result 
confirmed the formation of interepithelial adherens junctions, in cells expressing WT E-Cadherin 
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(Maeda et al. 2006). However, the paracellular flux through monolayers of cells expressing the E-
Cadherin cis interface mutants was statistically similar to the non-transfected control cells (Fig 
4.6, p > 0.1). Namely, in the 2.5 hr. observation time, less than 0.2% of the dye leaked across 
monolayers of cells expressing WT E-cadherin. The latter was significantly lower than the flux 
through control monolayers or monolayers of cells expressing the mutants (control vs WT E-
cadherin; p=0.004, N=6). The paracellular flux through either control cell monolayers or through 
monolayers expressing the mutants were statistically similar (p > 0.05 for all pairwise 
comparisons; Nexp = 6, for each condition).  
4.4 Discussion 
The kinetic signatures of cadherin-mediated intercellular binding reveal enhanced protein-protein 
interactions within confined adhesion zones. Adhesion frequency measurements of cadherin-
mediated intercellular binding exhibit unique, two-stage kinetics described by a rapid initial 
increase in binding probability to P1 (Fig 4.2), followed by a short lag and then a further, slower 
increase to a final steady state plateau at P2 (Fig 4.3). The first, fast binding step is due to trans 
(adhesive) dimerization between the N-terminal EC1 domains (Fig 4.3). It is known that the 
cadherin-inactivating W2A mutation diminishes the fast, initial binding step, and point mutations 
at the trans-binding interface quantitatively altered the affinity of the initial binding interaction 
(Chien et al. 2008; Tabdili et al. 2012). The onset of the second increase in binding probability 
thus reveals the formation of additional cadherin interactions at the cell-cell junction that were not 
detected in solution binding assays.  
The impact of the cis (lateral) binding interface mutants (see Fig 4.2 and 4.3) on the kinetic 
signatures provided compelling evidence that the second kinetic step is due to lateral ectodomain 
interactions. All three mutants V81D, L175D and V81D/L175D impeded or blocked the second 
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kinetic process, without altering the initial trans binding affinities. These same recombinant 
cadherins also exhibited similar trans binding affinities in solution (Harrison et al. 2011). The 
increased binding probability attributed to lateral cadherin association may also be explained by 
cooperativity between adhesive and lateral interactions predicted by simulations (Wu et al. 2010).  
The effects of N-glycosylation on the two-stage binding kinetics of neural N-cadherin 
further support this interpretation of the kinetics signature (Langer et al. 2012). De-glycosylating 
N-cadherin ectodomains—thereby removing possible steric impediments to lateral association—
accelerated the rise to P2 (Langer et al. 2012). Conversely, E-cadherin hypo-glycosylation, which 
would reduce lateral steric interference, resulted in tighter inter-epithelial junctions (Nita-Lazar et 
al. 2010b). Also, removing the EC3 domain near the putative cis interface or deleting EC3-5 
abolished the second kinetic step (Chien et al. 2008). Although EC3 is not directly involved in the 
putative lateral binding interface, a possible explanation for the latter results is that the EC3 
deletion allosterically disrupts the lateral interactions. Mutations at the EC2/EC3 junction disrupt 
trans binding, and antibodies against ectodomain epitopes outside the binding site, as well as the 
phosphorylation state of the cytoplasmic binding partner p120 catenin, alter E-cadherin affinity 
(Becker et al. 1999; Handschuh et al. 1999; Handschuh et al. 2001; Prakasam et al. 2006; Petrova 
et al. 2012; Shashikanth et al. 2015).  The kinetic data cannot directly verify the molecular details 
of the cadherin interactions but nevertheless, the kinetic effects of disrupting putative lateral (cis) 
bonds or de-glycosylating ectodomains support a model in which the two-stage kinetic signature 
reflects initial trans (adhesive) binding, followed by adhesion-enhanced lateral interactions that 
further increase the binding probability. 
At the low cadherin surface densities used, the putative oligomerization at the onset of the 
second kinetic step likely involves only a few proteins. At reported cadherin (and membrane 
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protein) diffusivities from 0.036 down to 0.002µm2/s (Kusumi et al. 1993; Sako et al. 1998; Iino 
et al. 2001), it could take 7 to 80s, respectively, for two cadherins on the same membrane to collide. 
The closer proximity of the cadherins bound by bivalent antibodies on the RBCs might accelerate 
the process. Our results would nevertheless suggest that the ‘cluster’ sizes are small.  
The kinetics revealed cadherin interactions that presage the organization of cadherin at cell-
cell junctions. Between A431D cells expressing E-cadherin, the rapid rise to P2 corresponded with 
the formation of large cadherin puncta and tight intercellular barriers, apparent from permeability 
and wound healing results. Conversely, a slowed (or abolished) rise to P2 indicated impaired 
cadherin interactions that in turn resulted in smaller, more diffuse cadherin clusters, leakier inter 
epithelial junctions, and increased wound-healing rates. The cis interface mutants V81D and 
V175D similarly reduced the rate of N-cadherin-dependent spheroid formation by L-cells, 
compared to cells expressing WT N-cadherin, and the cell boundaries were less defined             
(Garg et al. 2015). N-cadherin mutants postulated to disrupt lateral interactions also reduced the 
number of cadherin adhesions and the junction lifetimes (Bunse et al. 2013). 
The increase in binding probability after initial adhesive (trans) binding, suggests that 
intermembrane confinement facilitates additional (cis) cadherin interactions. Simulations 
predicted that inter membrane pinning (trans bond formation) and consequent reduction in 
cadherin fluctuations would reduce entropic repulsion between proteins, and enable lateral protein 
association (Wu et al. 2011). Consistent with both this postulate and the kinetic data, lateral 
interface mutants impeded the assembly of large clusters at cell-cell junctions (Strale et al. 2015), 
but not the formation of small clusters outside of adhesion zones (Strale et al. 2015; Wu et al. 
2015). Thus, the lateral interface mutants appear to primarily alter the kinetics, after the formation 
of adhesive bonds—that is, within intercellular gaps. Taken together, these findings support our 
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postulate that the kinetic signature reflects rapid, initial trans binding, followed by lateral cadherin 
interactions, which manifest at intercellular junctions but not in solution. 
Other investigations of the potential influence of confinement on lateral cadherin 
interactions and junction assembly focused on adhesion plaque nucleation. Cluster nucleation 
involves other, active biochemical processes that could eclipse the biophysical influence of 
confinement on ectodomain interactions (Yap et al. 1997; Yap et al. 1998; Shewan et al. 2005; 
Hong et al. 2013; Truong Quang et al. 2013; Biswas et al. 2015; Wu et al. 2015). In this study, the 
pre-steady-state binding events during the initial 40s of cell-cell contact were independent of the 
cadherin cytoplasmic domain and cytoskeletal interactions (Table 4.1); namely, both recombinant 
ectodomains and membrane bound WT E-Cad exhibited two-stage binding kinetics. The mutants 
exhibited similar trans (adhesion) binding kinetics/affinities, and mutants V81D and L175D 
exhibited residual putative lateral interactions; consequently, observed cluster nucleation alone 
may not be sufficient to distinguish subtler differences between the mutants and WT protein.  
The effects of mutants on wound healing, for example, were indistinguishable from each 
other, although all three cis mutants altered wound closure rates relative to WT E-Cadherin. The 
indistinguishable wound healing rates among the mutants may not be surprising because other 
processes contribute to collective cell migration, and could mask less pronounced binding 
differences. Similarly, tight junctions are well-known to regulate barrier permeability (Hartsock 
and Nelson 2008). Cadherins are required for tight-junction assembly and maintenance, and 
disrupting cadherin adhesions contributes to increased barrier leak in several examples (Lum and 
Malik 1994; Taddei et al. 2008; Komarova and Malik 2010; Nita-Lazar et al. 2010).  Because of 
the additional influence of tight junctions, permeability changes may also not be sensitive to more 
subtle differences between cadherin mutants. 
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In summary, these pre-steady-state cadherin binding kinetics revealed distinct, early 
cadherin ectodomain interactions, which contribute to cadherin organization at intercellular 
junctions and barrier function. Importantly, these kinetic data exposed a distinct, quantifiable 
kinetic process consistent with confinement-enhanced, lateral cadherin interactions. The 
identification of a quantitative, biophysical signature will enable future model testing and possible 
quantification of confinement-dependent perturbations to cadherin assembly at intercellular 
junctions.  
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4.5 Figures and Tables 
 
Figure 4.1. Proposed Cadherin Interactions at Cell-Cell Contacts. (a) Cadherins from 
opposing cells interact to form a transient intermediate, X-dimer, (b) which then converts to a an 
adhesive (trans) bond. (c) Upon adhesive (trans) bond formation, reduced protein fluctuations 
would result in decreased repulsion between adjacent proteins, and enable the formation of lateral 
interactions and larger cadherin clusters. 
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Figure 4.2. Binding Kinetics Membrane Bound E-Cadherin Ectodomain Variants. (a)  
Mutations at the putative lateral binding interface alter the binding kinetics of recombinant E-
cadherin ectodomains. The plot shows the binding probability versus contact time between two 
RBCs ectopically-modified with WT mouse E-Cad-His6 (black squares) or the mutants L175D 
(black circles), V81D (gray triangles) and V81D/L175D (white squares). The cadherin surface 
densities are summarized in Table 4.1. The solid line is a nonlinear least squares fit of the receptor-
ligand model to the data corresponding to the first kinetic (WT mouse E-cadherin), with best fit 
parameters summarized in Table 4.1. Controls (white circles) used RBCs without immobilized E-
Cad-His6.  
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Figure 4.3. Binding Kinetics Membrane Bound E-Cadherin Ectodomain Variants. Binding 
probability versus contact time between RBCs ectopically-modified with mouse E-Cad-His6 (WT 
or Double mutant), and A431D cells expressing Hu-E-Cad-GFP WT (black squares) or the 
V81D/L175D mutant (grey squares). The cadherin densities on the cell surface are summarized in 
Table 4.1. The solid line is the nonlinear least squares fit to the trans-dimer model of data 
corresponding to the first kinetic step (Hu-E-Cad-GFP WT), with best fit parameters given in the 
text and summarized in Table 4.1.  Controls (white squares) used A431D E-Cad-GFP WT cells 
and RBCs without immobilized E-Cad-His6.  
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Figure 4.4. Structured Illumination Microscopy (SIM) images reveal differences in cadherin 
organization among mutants. SR-SIM (Super Resolution- Structured Illumination Microscopy) 
of live A431D cells expressing the different Hu-E-Cad-GFP variants. The images compare wide 
field and processed SR-SIM images at a resolution of 150 nm. Images are shown for A431D cells 
expressing the different E-Cadherin variants, at cell-cell junctions. From left to right, the first two 
columns compare organization of E-cadherin GFP at cell-cell contacts, as observed by widefield 
or SR-SIM. The third column shows E-cadherin localization at contact-free edges of the cells. The 
fourth column shows the organization of E-Cad-GFP in a group of cells. Scale bars are 10 µm (4th 
column) and 2 µm for the remaining images.  
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Figure 4.5. Putative lateral interface mutants impair wound healing response (cell-cell 
migration). Scratch wound healing performed for A431D E-cad monolayers shown above after 
creating the wound and then complete wound closure. The percentage of (similar width) wound 
area remaining as a function of time after scratch wounding of a monolayer of A431D cells 
expressing WT Hu-E-Cad-GFP (black squares) or its mutants V81D (black circles), V175D (white 
circles) or V81D/V175D (white squares) at similar surface densities. The lines through the data 
are to guide the eye only.  
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Figure 4.6. Putative lateral interface mutants impair intercellular barrier integrity. 
Percentage of Evan’s Blue-labeled BSA leaked through cell-cell junctions from the basal chamber, 
as a function of time. Paracellular permeability measurements were performed with confluent 
monolayers of A431D cells expressing the different Hu-E-Cad-GFP variants cultured on a 
transwell support.  
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Table 4.1: Best-fit values of K2D and koff determined from kinetic data. The Left and Right 
sides refer to the cells held by the opposing micropipettes. The right side is the Red Blood Cell 
labeled with the indicated E-cadherin ectodomain. The cadherin densities (number/µm2) in 
parentheses were quantified by flow cytometry. 
*If the identity of the cell on the Left Side not given, then a Red Blood Cell labeled with the 
E-cadherin ectodomains indicated was used, in order to quantify the binding properties of 
isolated ectodomains. 
 
  
Left side micropipette 
(cadherins/m2)* 
Right side micropipette 
(cadherins/m2) 
KD (x 10-4 ) 
µm2 
koff (s-1 ) 
E-Cad-His6 WT (21) E-Cad-His6 WT (21) 3.3 ± 0.5 1.0 ± 0.2 
E-Cad-His6 L175D (22) E-Cad-His6 L175D (22) 3.0 ± 0.4 0.9 ± 0.1 
E-Cad-His6 V81D (24) E-Cad-His6 V81D (24) 2.4 ± 0.3 0.9 ± 0.2 
E-Cad-His6 V81D/L175D (16) E-Cad-His6 V81D/L175D(16) 3.5 ± 0.5 0.9 ±0.2 
A431D Hu-E-Cad WT (7) E-Cad-His6 WT (40) 3.1 ± 0.4 1.2±0.3 
A431D Hu-E-Cad 
V81D/V175D (8) 
E-Cad-His6 V81D/L175D 
(40) 
2.9 ± 0.3 1.1 ± 0.2 
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CHAPTER 5 
Role of Glycosylation in E-Cadherin Adhesion 
 
5.1 Introduction 
Posttranslational modification is one mechanism that regulates the function of adhesion proteins, 
like cadherins. Apart from direct phosphorylation of the cytoplasmic domain, glycosylation is the 
most common posttranslational modification in cadherins (Pinho et al. 2011). Both N-
glycosylation and O-glycosylation are prevalent in classical cadherins, with N-linked 
Glycosylation making up to ~20% of the molecular weight of cadherin itself (Fig 5.1) (Geyer et 
al. 1999; Liwosz et al. 2006; Pinho et al. 2009; Lommel et al. 2013).  
It is well established that N-glycosylation is essential not only for E-cadherin expression, 
folding and trafficking, but also for the stability of the adherens junctions (Pinho et al. 2011). 
Studies demonstrated that N-glycosylation affects the molecular composition and organization of 
cadherin junctions (Zhou et al. 2008; Jamal et al. 2009). In breast tumors, the ectodomains of E-
cadherin exhibit highly branched N-glycans on extracellular domains EC4 and EC5. 
Hyperglycosylation at the latter sites destabilized epithelial junctions and increased tumor 
progression (Pinho et al. 2009a; Pinho et al. 2009b; Bassaganas et al. 2014). Conversely, hypo-
glycosylation, achieved by treatment with a known glycosyl transferase inhibitor tunicamycin 
(Kitada et al. 2001; de Freitas Junior et al. 2011) or by mutating an N-glycosylation site in EC4 
enhanced intercellular junction assembly, cytoskeletal remodeling at junctions, and transepithelial 
resistance (Liwosz et al. 2006). More recent studies investigated the role of O- glycosylation, with 
particular emphasis on the first O-mannosylation step. In mouse embryos, depleting E-cadherin of 
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O-mannosylation affected embryonic development in mice and growth was arrested beyond the 
morula stage (Lommel et al. 2013; Winterhalter et al. 2013). Treating MDCK cells expressing E-
cadherin treated with an O-mannosylation specific antibody Tα1-mann reduced cell-cell 
aggregation (Lommel et al. 2013). The broad impact of N- and O-linked E-cadherin glycosylation 
on cell-cell adhesion and cadherin functions are not well understood.   
Structural studies cannot investigate the impact of glycosylation on cadherin interactions, 
because of the difficulty of obtaining crystal structures of glycosylated proteins. Adhesion 
frequency measurements, described in Chapter 2 are ideally suited to address this question. Prior 
adhesion frequency measurements of N-cadherin and its N-glycosylation mutants tested the 
hypothesis that N-glycosylation regulates cadherin binding function (Langer et al. 2012). The latter 
study demonstrated that N-glycosylation does not affect the trans-binding affinity, but instead 
alters the two-stage binding kinetics (Langer et al. 2012). Specifically, the binding kinetics 
measured with hypoglycosylated N-cadherin did not exhibit a lag phase, typical of classical WT 
cadherins. Instead, removing N-glycans resulted in a rapid rise in cadherin binding probability to 
steady state within 12s of cell-cell contact. Together with prior cross-linking results, the latter 
results support a mechanism in which initial, EC1-dependent trans binding is followed by 
additional cadherin interactions that enhance binding. The presence of N-glycans localized at three 
sites in the EC2-EC3 domains of N-cadherin slowed the second kinetic step, reduced wound 
healing rates, and increased the population of cadherin dimers on cell membranes (Guo et al. 2009).  
In this chapter, adhesion frequency measurements of E-cadherin N-glycosylation mutants 
investigated whether glycosylation similarly affected E-cadherin function. These initial results 
demonstrate the impact of hypoglycosylation on E-cadherin binding function. Two N-
glycosylation sites on E-cadherin (N404 and N483) tested the impact of N-clycans on E-cadherin 
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function. We further determined the impact of O-glycosylation, by expressing cadherin in HEK 
293T cell lines devoid of O-mannosyl transferases Pomt1 and Pomt2 genes. The latter cells were 
used to generate stable cell lines expressing E-cadherin devoid of O-glycosylation. The results 
described show that N-glycans in EC4 and EC5 of E-cadherin affect cadherin binding differently 
than N-cadherin. Hypo N-glycosylation prolonged the lag phase observed with WT E-cadherin, 
disrupted cluster formation at cell-cell junctions, and increased paracellular barrier integrity. O-
mannosylation deficient E-cadherins expressed in HEK 293T cells could not form cadherin 
plaques or differences in paracellular permeability. 
5.2 Materials and Methods 
5.2.1 Plasmids and Cell culture 
Unless mentioned specifically, all cell lines were cultured in standard Dulbecco’s Minimal Eagle’s 
Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS). 
The E-cadherin GFP plasmid obtained from Addgene (#27001) was used as the template 
to perform site-directed mutagenesis (described in detail in Chapter 4) at the specific N-
glycosylation sites. Both Asn404 (N404) and Asn483 (N483) were converted to Gln (Q). Primers 
used for this purpose were as follows: For N404Q, the forward primer used was 5’- 
GAGCACGTGAAGCAAAGCACGTACACA -3’. The reverse primer used was 5’-
CTGTGTACGTGCTTTGCTTCACGTGCTC -3’. For N483Q, the forward primer used was  
5’- GGGCGAGTGCCCAATGGACCATTCAG -3’. The reverse primer used was 5’- 
CTGAATGGTCCATTGGGCACTCGCCC -3’. A double mutant N404Q/N483Q was generated 
using the N483Q single mutant as a template. These mutants were transfected into A431D cells, 
and stable cell lines were generated as detailed as described in the Methods section of Chapter 4. 
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Cells were selected with G418 (geneticin sulfate) at a concentration of 400 µg/mL . The cell lines 
were each sorted to a median positive density of E-cadherin GFP, and monitored by flow cytometry 
to confirm E-cadherin surface expression. 
Since there are more than 20 potential O-glycosylation sites in E-cadherin distributed 
throughout the E-cadherin polypeptide (Vester-Christensen et al. 2013), it was not feasible to 
mutate all sites, apart from the possible effects on protein folding. Recently, the role of O-
mannosylation in E-cadherin had been tested using mice in which two critical genes encoding for 
isoforms of O-mannosyl transferases Pomt1 and Pomt2 were knocked out. Individual cells in these 
knockout mice were incapable of transferring sugars to potential Ser/Thr sites on proteins. The 
loss of O-glycans E-cadherin (Lommel et al. 2013) was confirmed in mice knockouts, with 
antibodies specific for O-mannosylated sites on E-cadherin.  
These studies used HEK 293T cells in which two isoforms of the O-mannosyl transferase 
enzyme were knocked out (HEK293T ∆Pomt1 and HEK 293T ∆Pomt2 respectively). The latter 
cells were a gift from Prof. Sabine Strahl at University of Hiedelberg, Germany (Lommel et al. 
2013). Because these cell lines were already resistant to the antibiotic G418, the Hu Ecad GFP 
gene was cut out from pcDNA 3.1 and cloned into pCDH 501-B vector, which contains a 
puromycin selection marker. The HEK 293T cell lines were then transfected with this plasmid and 
stable cell lines were created by fluorescence sorting for positive GFP expression. The sorted cells 
were cultivated in DMEM supplemented with puromycin dihydrochloride (3 µg/mL).  
5.2.2 Assays  
Adhesion frequency measurements (Chapter 2, Section 2.2) quantified the effect of E-cadherin N-
glycosylation mutants on the cadherin binding kinetics. Super resolution- structural illumination 
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microscopy (SR-SIM Chapter 3, Section 4.2.7) imaged the localization and aggregation of E-
cadherin N-glycosylation mutants at intercellular junctions. Paracellular permeability 
measurements (Chapter 4, Section 4.2.6) investigated the effect of E-cadherin N-glycosylation 
mutants on intercellular barrier integrity.  
5.3 Results 
5.3.1 E-Cadherin N-Glycosylation Alters Cadherin Binding Kinetics, But Not Trans 
Binding Affinity 
A431D cells stably expressing either E-cadherin (WT), or E-cadherin with N-glycosylation 
mutations-N404Q, N483Q or N404/N483Q were used in the adhesion frequency measurements. 
Binding kinetics were measured between A431D cells expressing E-cadherin variants at 
determined densities and WT- canine E-cad ectodomains immobilized on the red blood cells. All 
of the E-cadherin variants were expressed on A431D cells at similar surface densities of ~10 
cadherins/µm2 (Table 5.1). The density of E-cadherin ectodomains on the labeled RBCs are given 
in Table 5.1.  
In adhesion frequency measurements between WT E-cad on A431D cells and canine E-
cad-Fc, the binding probability followed the typical biphasic kinetic course observed with E-
cadherin, where an initial rapid rise in binding was followed by a lag up to 7s, followed by a further 
increase to a final steady state probability at 20s (Fig 5.2.A and B). In contrast, the individual N-
glycosylation mutant, N404Q, as well as the double mutant both displayed a lower binding 
probability, and a subsequent delay in the onset of the rise in the second phase. With the N404Q 
mutant, the lag phase persisted up to 15s (Fig 5.2.B). With the double mutant, the lag persisted for 
12s, and then the binding frequency increased to steady state at 20s. The N483Q mutant behaved 
similar to the L175D/V81D cis-mutant (Chapter 4.3.2); namely, the binding profile was almost 
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monophasic. F-tests indicated that first binding step measured with N404Q and the double 
glycosylation mutant N404Q/N483Q exhibited an extended lag phase (Fig 5.2A). By contrast, the 
N483Q mutant exhibited a simple exponential rise to a single steady state probability (Fig 5.2B). 
The latter mutant appeared to inactivate lateral cadherin interactions. Interestingly, the calculated 
binding parameters (K2D, koff) of the N-glycosylation mutants were statistically similar to E-
cadherin WT as well as each other (t-test, p>0.05 in all cases).  
5.3.2 Deglycosylated E-Cadherin Impaired Barrier Integrity And Resulted In Diffuse 
Distribution Of Cadherins At Cell-Cell Junctions 
5.3.2a Effect of point mutations on N-glycosylation sites 
Super resolution structured illumination microscopy (SR-SIM) imaging determined whether 
deglycosylation of E-cadherin altered the organization of E-cadherin both at A431D intercellular 
junctions. SR SIM images revealed distinct punctate cadherin plaques at junctions between A431D 
cells stably expressing WT Hu-E-cad GFP. The adhesion plaques observed between live (unfixed) 
A431D cells expressing WT Hu-E-cad GFP (Fig 5.3) were similar to the large, dense cadherin 
plaques at junctions observed in SR-SIM and 3D-STORM images (Wu et al. 2015; Shashikanth et 
al. 2016). However, such puncta were not visible when cells expressed the E-cadherin 
N404Q/N483Q mutant, and the clusters were smaller and more diffuse at cell-cell junctions (Fig 
5.3).  
Paracellular permeability measurements also tested the impact of these mutants 
intercellular barrier integrity. Measurements with confluent monolayers of A431D cells expressing 
E-cadherin-GFP revealed that the expression of WT Hu-E-cad GFP reduced epithelial barrier 
permeability significantly, relative to untransfected A431D cell monolayers (Fig 5.4). However, 
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junctions between A431D cells expressing the N404Q/N483Q mutant showed similar Evans-blue 
conjugated BSA permeability compared to untransfected A431D cells (Fig 5.4). Hence E-cadherin 
N-glycosylation mutants increased epithelial barrier permeability, in contrast to prior reports 
suggesting that these mutations enhanced epithelial barrier integrity. 
5.3.2b Effect of removing O-glycosylation of E-Cadherin 
SR-SIM imaging was performed on HEK 293T cell lines, which expressed WT Hu-E-cad GFP 
(HEK WT-Ecad), or Hu-E-cad GFP without O-mannosylation on ectodomains (HEK ∆Pomt1-
Ecad and HEK ∆Pomt2-Ecad). Images obtained with these cell lines are shown in Fig 5.5. 
Surprisingly, even WT E-cadherin expressed in HEK 293T cells did not form plaques. Similarly, 
the O-mannosylation defective mutants expressed E-cadherin, but the protein distribution was 
diffuse at the cell-cell junctions. This was not surprising because even the HEK WT Hu-E-cad 
GFP cells exhibited similar behavior. This may be due to the expression of E-cadherin in 
fibroblasts like HEK 293T, which may not contain or express all of the molecular machinery 
required to form adherens junctions. 
This lack of E-cadherin organization into plaques correlated with the paracellular 
permeability observed with these cell lines (Fig 5.4). These cell monolayers were permeable to 
Evans-blue BSA to the same extent as the HEK parental cells expressing WT Hu-E-cad GFP cells, 
suggesting that the barrier integrity was independent of the O-mannosylation status.  
5.4 Discussion 
This study focused on the impact of N-linked and O-linked glycosylation on E-cadherin mediated 
cell-cell binding kinetics and on the possible physiological implications of hypoglycosylation. In 
contrast to prior reports, which suggested that ablating N-glycosylation on E-cadherin enhanced 
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cell-cell cohesion (Liwosz et al. 2006; Jamal et al. 2009; Nita-Lazar et al. 2010; Varelas et al. 
2014), the preliminary results described here suggest that this may not reflect protein level 
interactions. The binding kinetics show that deletion of N-glycosylation prolonged the lag phase 
up to 15s of contact. If we attribute the second phase to enhance binding due to lateral interactions 
as discussed in Chapter 4 (Chien et al. 2008; Langer et al. 2012; Shashikanth et al. 2016), then 
these results would suggest that the N-glycosylation mutants impede lateral E-cadherin 
interactions.  
The different kinetic effect of ablating N-glycans on E-cadherin could be due to the 
locations of these glycans in the protein structure, as they differ from N-glycosylation sites on N-
cadherin. N-cadherin is N-glycosylated at 8 different locations on its ectodomain (Guo et al. 2009). 
Of these locations, three sites are on EC2 and EC3, which when mutated, resulted in enhanced 
cell-cell adhesion (Guo et al. 2009; Langer et al. 2012). The glycans could sterically impede the 
formation of lateral interactions, because the EC2 and a part of the EC3 domain are involved in 
the formation of the putative cis-interface (Harrison et al. 2011). In E-cadherin, however, the N-
glycosylation sites are concentrated on EC4 and EC5. Additionally, there is conflicting evidence 
regarding the role of N483 in E-cadherin expression and activity. One study with MDCK cells 
suggested that, even though the expression levels of E-cadherin glycosylation mutants was lower 
than that of WT E-cadherin, the localization of junction associated proteins was unaffected. 
However, a similar study with MDA-MB-235 cells, showed that the N483Q mutation impaired E-
cadherin folding and trafficking (Zhao et al. 2008; Zhou et al. 2008). The latter behavior affected 
phosphorylation of β-catenin, and resulted in junctional instability (Kitada et al. 2001; Zhao et al. 
2008). 
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In A431D cells, however, we observed that both WT E-cadherin and N-glycosylation 
variants localized similarly at cell-cell junctions. The E-cadherin surface expression levels were 
also similar in these cell lines. This result suggests that ablating the N-glycosylation sites in E-
cadherin did not affect E-cadherin expression or localization at junctions. Also, based on the 
similar affinities and off-rates of the WT E-cadherin and N-glycosylation mutants, N-glycans do 
not appear to alter EC 1-2 mediated cadherin trans interactions.  
The kinetic signatures correlated with the organization and physiological impact of the N-
glycosylation mutants, similar to the cis-interface mutants discussed in Chapter 4. Cadherin 
localization at cell-cell junctions observed by SR-SIM was diffuse. This was further supported by 
the observation that, with cells expressing the mutants, paracellular permeability was significantly 
higher compared to cells expressing WT E-cadherin. This result suggested that the barrier integrity 
was compromised, due to the inability of cadherins to form plaques at the junctions. This results 
is also contrary to prior reports. Transepithelial resistance (TER) assays performed with MDCK 
expressing E-cadherin mutants (N404Q, N483Q or N404Q/N483Q) showed that the junctions 
were less permeable to ion flux (Nita-Lazar et al. 2010). However, paracellular permeability of 
macromolecules like BSA was not measured in those studies. The permeability of intercellular 
junctions to macromolecules and small ions is largely controlled by tight junction proteins. Results 
from the same study also suggested that the N483Q mutant correlated with the recruitment of the 
protein PP2A to tight junctions, which is further associated with stronger claudin and occludin 
(tight junction protein) interactions (Nita-Lazar et al. 2010). Previous studies showed that tight 
junction formation increased electrical resistance by reducing ion flux, in contrast increased 
macromolecular flux by activating a ‘leak’ pathway (Balda et al. 1996). The latter findings are 
consistent with the macromolecule permeability reported in this study.  
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O-Mannosylation of E-cadherin is essential to development (Vester-Christensen et al. 
2013). Mouse embryos failed to develop from the morula to the blastocyst stage because of defects 
in the molecular architecture of cell-cell contact sites, including the adherens and tight junctions 
(Lommel et al. 2013). Preliminary data described in this chapter did not generate any conclusive 
results that could shed light on the role of O-mannosylation. Both paracellular permeability and 
SR-SIM measurements showed that hypoglycosylation had no effect on the epithelial barrier 
integrity or the organization of cadherins at intercellular junctions. A possible explanation is that 
HEK 293T cells do not form well-organized intercellular junctions, and are therefore not model 
cell lines for studies of cadherin junctions. HEK 293T cells are fibroblasts, which may not contain 
the molecular machinery to form organized cell-cell adhesions.  
This study thus far reveals that N-glycosylation of E-cadherin, contrary to its influence on 
N-cadherin function, negatively regulates E-cadherin junction assembly, by altering binding 
kinetics in ways that correlate with less organized cadherins at cell-cell junctions. This suggests 
that glycosylation may have a more site-specific rather than general impact on E-cadherin 
functions. In future work, more extensive experiments need to be performed, especially with 
deglycosylated cadherins on the red blood cells, to further investigate the impact of these 
glycosylation mutants. This can be achieved by expressing E-cadherin ectodomains in a vector 
with a CD 33 signal which secretes proteins into cell culture media, after their expression. Further, 
cell lines that can form proper cadherin junctions, like MDCK or A431D epithelial cells will be 
more relevant for these studies. 
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5.5 Figures and Tables 
 
 
 
Figure 5.1: E-cadherin post-translational modifications (adapted from (Lommel et al. 2013; 
Neubert et al. 2016)). A. The extracellular domain (EC) of human E-cadherin contains four 
potential N-glycosylation sites, which are located in EC4 and EC5. B. Schematic drawing of O-
mannosylation on extracellular domains of classical type 1 cadherins: White circles illustrate 
potential O-Man glycosites predicted based on sequence conservation of Ser/Thr residues in 
alignments. Green-white circles show glycosites that were ambiguously identified. Predicted O-
GalNAc sites based on sequence identity are depicted as white squares. 
  
A 
B 
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Figure 5.2. A. Comparison of the binding kinetics of WT-E-cadherin with the N404Q/N483Q 
glycosylation mutant. The plot shows the binding probability versus contact time between RBCs 
ectopically-modified with Canine E-Cad-Fc (WT), and A431D cells expressing Hu-E-Cad-GFP 
WT (blue) or Double Glycosylation mutant N404Q/N483Q (red). The cadherin densities on the 
cell surface are summarized in Table 5.1. The solid (WT E-cad) and dashed (N404Q/N483Q E-
cad) lines are the nonlinear least squares fit of the trans-dimer model (Equation XX) to data 
corresponding to the first kinetic step, with best fit parameters given in the text and summarized 
in Table 5.1.   
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Figure 5.2 (cont.)  
 
Figure 5.2. B. Binding Kinetics point mutants that disrupt E-cadherin N-Glycosylation sites: 
N404Q and N483Q. Binding probability versus contact time between RBCs ectopically-modified 
with Canine E-Cad-Fc (WT), and A431D cells expressing Hu-E-Cad-GFP N404Q (blue) or 
N483Q (red). The cadherin densities on the cell surface are summarized in Table 5.1. The solid 
(N404Q E-cad) and dashed (N483Q E-cad) lines are the nonlinear least squares fit to the trans-
dimer model of data corresponding to the first kinetic step with best fit parameters given in the 
text and summarized in Table 5.1.   
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Figure 5.3. Structured Illumination Microscopy (SIM) images of A431D cells expressing N-
glycosylation mutants. SR-SIM (Super Resolution- Structured Illumination Microscopy) of live 
A431D cells expressing the different Hu-E-Cad-GFP variants – (A) N404 glycosylation mutant 
(B) N404Q/N483Q glycosylation mutant. The organization of E-cadherin at cell-cell junctions do 
not resemble that of WT-E-cadherin (Fig 4.4, Chp. 4), but are more punctate than cis-interface 
mutants. 
  
A 
B 
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Figure 5.4. Paracellular permeability studies on N- and O-linked glycosylation mutants. 
Percentage of Evan’s Blue-labeled BSA leaked through cell-cell junctions from the basal chamber, 
determined with the different N- and O-glycosylation mutants. Paracellular permeability 
measurements were performed with confluent monolayers of A431D cells expressing the different 
Hu-E-Cad GFP variants cultured on a transwell support.  
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Figure 5.5. Structured Illumination Microscopy (SIM) images of HEK 293T cells expressing 
O-glycosylation mutants. SR-SIM (Super Resolution- Structured Illumination Microscopy) of 
live HEK 293T cells expressing the different Hu-E-cad GFP variants – (A) WT-E-cad-GFP (B) 
O-mannosyltransferase Pomt2 knockout Hu-E-cad GFP. The organization of E-cadherin at cell-
cell junctions does not resemble that of WT Hu-E-cad (Fig 4.4, Chapter 4), and is completely 
diffuse. 
  
A 
B 
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Table 5.1. Best-fit values of K2D and koff determined from kinetic data. The Left and Right 
sides refer to the cells held by the opposing micropipettes. The right side is the Red Blood Cell 
labeled with the indicated E-cadherin ectodomain. The cadherin densities (number/µm2) in 
parentheses were quantified by flow cytometry. 
 
  
Left micropipette 
(cadherins/m2) 
Right micropipette 
(cadherins/m2) 
KD (x 10-4 ) 
µm2 
koff (s-1 ) 
A431D Ecad WT (7) E-Cad-Fc WT (40) 3.1 ± 0.5 1.0 ± 0.2 
A431D Ecad N404Q (10) E-Cad-Fc (22) 2.0 ± 0.3 1.1 ± 0.3 
A431D Ecad N483Q (10) E-Cad-Fc (24) 2.7 ± 0.3 0.7 ± 0.2 
A431D Ecad N404Q/N483Q (10) E-Cad-Fc (58) 2.5 ± 0.4 0.5 ±0.2 
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Chapter 6 
Conclusions and Future Work 
 
6.1 Conclusions 
6.1.1 Inside-out Allosteric Regulation of E-cadherin 
From adhesion frequency measurements performed on cadherin expressing cells devoid of α-
catenin expression, enabled us to conclude that α-catenin had a modest effect on the trans binding 
affinity of E-cadherin mediated by homophilic bonds. It did not affect the overall kinetic signature 
when compared to WT α-catenin expressing MDCK cells. This was a first example of inside-out 
regulation of cadherin activity by a molecule which connects cadherins to the actin cytoskeleton 
indirectly.   
Adhesion frequency measurements enabled the quantitative demonstration of allosteric 
regulation of homophilic, E-cadherin binding by p120ctn phosphorylation status. Here, the initially 
low E-cadherin K2D results in low binding probabilities Activating antibody allosterically altered 
the E-cadherin cytoplasmic domain, resulting in p120ctn de-phosphorylation by outside-in 
signaling (Petrova 2012). Inside-out signaling due to p120 catenin de-phosphorylation then 
increased the cadherin affinity, which increased the measured cell-cell binding probability.  The 
activating antibody had no detectable effect on isolated cadherin ectodomains, as expected, if the 
fragments adopt a constitutively activate conformation. Neither the antibodies nor the change in 
p120 phosphorylation status affected localization and clustering of E-cadherin in single, isolated 
cells, which proved that the measured changes in affinity was due to an overall change in activity 
and not mediated by localized clustering. 
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6.1.2 Regulation of Cadherin Mediated Adhesion by Cis Interactions 
We identified a unique kinetic signature, which was indicative of confinement-enhanced, lateral 
cadherin interactions. Mutations which perturbed a putative cis-interface affected this kinetic 
signature qualitatively without affecting its trans dimerization affinity. The measurements with 
recombinant cadherin ectodomains and with full-length cadherins further confirmed that the 
kinetic signatures were independent of cytoskeletal interactions. Comparisons of kinetics with cell 
and tissue functions revealed the potential physiological significance of these findings. The 
mutations resulted in faster wound healing response to less cell-cell cohesion, and reduced, diffuse 
clustering of cadherins at cell-cell junctions which resulted in a loss of barrier integrity, as 
quantified by paracellular permeability measurements. 
6.1.3 Regulation of Cadherin Interactions by N and O Linked Glycosylation 
From Chapter 5, preliminary results suggest that unlike N-cadherin hypo-glycosylation, Hypo N-
glycosylation of E-cadherin resulted a delayed onset of lateral interactions, which correlated with 
lesser clustering at cell-cell junctions and enhanced permeability (loss of barrier integrity). Initial 
reports suggest that removal of O-linked glycosylation did not support cadherin clustering at all, 
resulting in diffuse junctions and leaky barriers to begin with. Overall, this is a significant finding 
which informs us that the role of glycosylation among cadherins is dependent on its location on 
the cadherin ectodomain. 
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6.2 Future Work 
The importance of N and O-linked glycosylation in regulating cadherin adhesion has been a focus 
of how adhesion mechanisms correlate with cancer and diseases which involve genetic defects in 
glycosylation, like muscular dystrophy. The outcomes mentioned in chapter 5 are preliminary, and 
must be investigated using additional techniques which could look at whether glycans play a role 
as a steric barrier, or whether they can modulate adhesion by interacting with cadherin ectodomains 
or other proteins on the cell membrane. The signaling pathway by which glycosylation at different 
positions on the ectodomains result in differential regulation of adhesion must be investigated. 
Molecular dynamics modelling could give us a clue to see if it is indeed the case. 
Although we have obtained evidence for p120 catenin and α-catenin involvement in 
regulation of cadherin homophilic binding, we do not understand the contribution of β-catenin in 
regulation of cadherin activity. Moreover, we do not understand if this regulatory process is 
essential for all cadherins. Finally, it will be important to understand how force on cadherin-
mediated cell-cell junctions reflects on the allosteric regulation mechanism, i.e., in other words, if 
mechanical tension is a part of the dynamic allostery exhibited by cadherins.  
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